Pharmacognostical, Phytochemical , Formulation and Evaluation of Hypolipidemic and Anti-Obesity Activity on Heartwood of Caesalpinia Sappan Linn by Mekala, K
  
PHARMACOGNOSTICAL, PHYTOCHEMICAL , FORMULATION AND 
EVALUATION OF HYPOLIPIDEMIC AND ANTI-OBESITY ACTIVITY ON 
HEARTWOOD OF Caesalpinia sappan Linn., 
 
A dissertation submitted to 
 
THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY 
CHENNAI - 600 032 
 
In partial fulfillment of the requirements for the award of degree of 
 
MASTER OF PHARMACY 
IN 
PHARMACOGNOSY 
Submitted by 
 
REG.NO:261420661  
 
Under the guidance of 
DR.  R.RADHA  M.Pharm., Ph.D., 
 
Department of Pharmacognosy 
College of Pharmacy 
Madras Medical College 
Chennai – 600003. 
APRIL 2016 
 
  
 
CERTIFICATE 
 
 This is to certify that the dissertation entitled “PHARMACOGNOSTICAL, 
PHYTOCHEMICAL, FORMULATION AND EVALUATION OF HYPOLIPIDEMIC 
AND ANTI-OBESITY ACTIVITY ON HEARTWOOD OF Caesalpinia sappan Linn.,” 
submitted by Reg.No: 261420661 in partial fulfillment of the requirements for the award of 
the degree of MASTER OF PHARMACY IN PHARMACOGNOSY by The Tamil Nadu 
Dr.M.G.R. Medical University, Chennai, is a bonafide record of work done by her  in the 
Department of Pharmacognosy, College of Pharmacy, Madras Medical College,  
Chennai-600003, during the academic year 2015- 2016 under the   guidance of  
Dr. R.RADHA M.Pharm, Ph.D., Department of Pharmacognosy, college of pharmacy, 
Madras Medical College, Chennai-600003. 
 
 
 
 
DR.A.JERAD SURESH,M.Pharm., Ph.D.,M.B.A., 
Principal, 
College of Pharmacy, 
Department of Pharmacognosy, 
Madras Medical College, 
Chennai – 600003. 
Place: Chennai  
Date: 
 
  
 
CERTIFICATE 
 
 This is to certify that the dissertation entitled “PHARMACOGNOSTICAL, 
PHYTOCHEMICAL, FORMULATION AND EVALUATION OF HYPOLIPIDEMIC 
AND ANTI-OBESITY ACTIVITY ON HEARTWOOD OF Caesalpinia sappan Linn.,” 
submitted by Reg.No: 261420661 in partial fulfillment of the requirements for the award of 
the degree of MASTER OF PHARMACY IN PHARMACOGNOSY by The Tamil Nadu 
Dr.M.G.R. Medical University, Chennai, is a bonafide record of work done by her  in the 
Department of Pharmacognosy, College of Pharmacy, Madras Medical College,  
Chennai-600003, during the academic year 2015- 2016 under the   guidance of  
Dr. R.RADHA M.Pharm, Ph.D., Department of Pharmacognosy, college of pharmacy, 
Madras Medical College, Chennai-600003. 
 
 
 
 
Dr.R. Radha ,M.Pharm.Ph.D., 
Professor ,Head of the department 
College of Pharmacy, 
Department of Pharmacognosy, 
Madras Medical College, 
Chennai – 600003. 
Place: Chennai  
Date: 
  
ACKNOWLEDGEMENT 
I wish to acknowledge my sincere thanks and express my heartful gratitude to the 
following persons with whose help and encouragement, I have completed this project work 
successfully. 
I express my first and foremost respect and gratitude to Almighty GOD with whole 
blessings I was able to complete my project work. 
I am grateful to express my sincere thanks to Dr. R .VIMALA, M.D., Dean, Madras 
Medical College, forgiving an opportunity to carry out my project work. 
I acknowledge my sincere thanks to Prof. Dr.A.Jerad Suresh, M.Pharm., Ph.D., 
MBA., Principal, College of Pharmacy, Madras Medical College for his support in carrying 
out my dissertation work in this institution. 
I extend my heartfelt gratitude to my guide Dr.R.Radha, M.Pharm., Ph.D., 
Professor and Head, Department of Pharmacognosy, College of Pharmacy, Madras Medical 
College, for providing me with all the necessary facilities and valuable guidance for my 
project work. 
I am much privileged to take this opportunity with pride and immense thanks 
expressing my deep sense of gratitude to  Dr.N.Jayashree, M.Pharm., Ph.D., Department 
of Pharmacology, Madras Medical College, for her constant inspiration, endless 
consideration and memorable guidance for the successful completion of my work. 
It’s a great pleasure for me to acknowledge my sincere thanks to all the Teaching 
staff members Dr. P.Muthusamy, M.Pharm., Ph.D., BL., Dr.R.Vijaya Bharathi, 
M.Pharm., Ph.D., and Dr.R. Vadivu, M.Pharm., Ph.D., and of the Department of 
Pharmacognosy for their valuable guidance and excellent co-operation.  
I acknowledge my sincere thanks to Dr. SEENIVELAN, B.V.Sc., Special 
Veterinary Officer and Mr.Kandaswamy and Mr. Kumar Assistants of Animal 
Experimental House, Madras Medical College, Chennai-03 for their support in carrying out 
my dissertation work in this institution. 
 
I express my sincere thanks to the Government of Tamilnadu for providing the 
financial support during my entire Post Graduate curriculum. 
I take this opportunity to express my thanks to V.Chelladurai, Research  officer- 
Botany, Central Council for Research in Ayurveda and Siddha, Tirunelvelli for collection and 
identification of this plant material. 
I take this opportunity to express my thanks to Prof. P. Jayaraman., Ph.D., Director, 
(PARC) and Mr. Manikandan, (PARC), Chennai, for Histological studies of this plant 
material. 
I thank Mrs T.S.Lakshmi, Mrs. M .Kumudha, Lab Technicians of Department of 
Pharmacognosy, Madras Medical College, and R .Indira, Chennai for their help during my 
research work. 
I express my sincere thanks to Mrs.V.Geetha, Manager of quality control, ATOZ 
Pharmaceuticals, Ambattur, for their quality control and HPLC work done in my project. 
I extend my sincere love and sense of gratitude to my beloved father Mr. 
K.M.Karuppaiyah (Late), for his continuous blessings to achieve my goal throughout my 
life. 
I am so happy to express my sincere love and sense of gratitude to my beloved Mother, 
Husband Mr.S.Rajendran, my lovable kids S.R.Tarun & S.R.Keerthiga, Brother and my 
family members for their excellent cooperation and support extended throughout my project. 
I express my special thanks to my best friends Mr.L.Karthick, B.Pharm., MBA., 
Mrs.V.Jayshree karthick M.Pharm.,  Mr.V.Thiyagarajan, M.Pharm., and  
Mr. G.Arun kumar, M.Pharm., for their support , ingenious suggestions and 
encouragement to achieve the M.Pharmacy degree.  
 I express my special thanks to my  Batchmates  Mr. A.Umesh, Miss. P.Vijayalakshmi, 
Miss.M.Sundarambal and  to my all  friends , seniors and juniors  of my department for their  
warm encouragement and thoughtfull guidance during this work. 
REG.NO:261420661 
CONTENTS 
 
 
 
 
  
S.NO TITLE 
PAGE 
NO 
1 INTRODUCTION 1 
2 REVIEW OF LITERATURE 8 
3 ETHNOBOTANICAL SURVEY 10 
4 RATIONALE FOR SELECTION OF THE PLANT 16 
5 AIM AND OBJECTIVE OF THE STUDY 17 
6 PLAN OF WORK 18 
7 MATERIALS AND METHODS 
7.1 Pharmacognostical studies 
7.2 Phytochemical studies 
7.3 Formulation of herbal capsule 
7.4 Pharmacological studies 
20 
8 RESULTS AND DISCUSSION 58 
9 SUMMARY AND CONCLUSION 97 
10 REFERENCES  
11 ANNEXURE  
LIST OF TABLES 
Table 
No Title 
Page 
No 
1. Normal levels of lipids 4 
2. Normal and abnormal level of lipids 5 
3. Herbs with hypolipidemic and anti-obesity activity 7 
4. Development of formulation 45 
5. Final batch composition- 250mg/capsule 47 
6. Acceptance criteria I.P limits 49 
7. Climatic zones and derived storage condition 51 
8. HFD induced hyperlipidemia &obesity model  55 
9. Macroscopical characters of Caesalpinia sappan heartwood 58 
10 Physiochemical constants  65 
11. Qualitative estimation of inorganic elements of Caesalpinia 
sappan 
66 
12. Quantitative estimation of inorganic elements of Caesalpinia 
sappan 
66 
13. Quantitative estimation of heavy metals 67 
14. Percentage yield of hydroalcoholic extract of Caesalpinia 
sappan 
68 
15. Qualitative phytochemical analysis 68 
16. Quantitative estimation of flavonoids present in hydroalcoholic 
extract 
70 
17. Quantitative estimation of phenolic content present in 
hydroalcoholic extract 
71 
18. Quantitative estimation of total saponin content 71 
Table 
No Title 
Page 
No 
19. Fluorescence analysis of powder and extract of Caesalpinia 
sappan at short and long UV 
72 
20. TLC of extract at different solvent system 73 
21. Solvent system for HPTLC 73 
22. HPTLC profile for extract  76 
23. Foreign organic matter determination 77 
24. Microbial load analysis 77 
25. Preformulation studies 78 
26. Evaluation of inprocess parameters 78 
27. Organoleptic characters of capsules 79 
28. Physical parameters of capsule 80 
29. Preliminary screening of capsule 81 
30. Quantitative estimation of flavonoids present in each capsule 82 
31. Quantitative estimation of phenolic content present in each 
capsule 
82 
32. Observation of acute toxicity study 83 
33. Changes in body weight 84 
34. Evaluation of organs weight 85 
35. Effect of HECS herbal capsule on lipid profile 86 
36. Effect of HECS herbal capsule on AI& LDL/HDL 87 
37. Effect of HECS herbal capsule on liver function test 88 
 
 
 
 LIST OF FIGURES 
Table 
No 
Title Page 
No 
1. Coronary artery disease 2 
2. Cerebrovascular disease 2 
3. Atherosclerosis 3 
4. Bad vs Good cholesterol 5 
5. Obesity 5 
6. Caesalpinia sappan whole plant view 14 
7. Caesalpinia sappan  plant 14 
8. Caesalpinia sappan spiny trunk 14 
9. Caesalpinia sappan pods 15 
10. Caesalpinia sappan flowers 15 
11. Caesalpinia sappan heartwood 15 
12. Herbal capsule 48 
13. OECD guidelines 53 
14. T.S of heartwood showing vessel distribution 59 
15. T.S of heartwood showing vessels, growth ring 59 
16. T.S of heartwood showing radial multiples of vessels 60 
17. TLS of heartwood showing axial parenchyma 61 
18. TLS of heartwood showing gum, biseriate xylem rays  61 
19. TLS of heartwood showing horizontal ribbon shaped ray 62 
20. RLS of heartwood showing horizontal ribbon shaped ray 63 
Table 
No 
Title Page 
No 
21. RLS of heartwood showing horizontal ribbon shaped ray enlarged 63 
22. Xylem fibers 64 
23. Pitted vessel 64 
24 Graphical representation showing standard curves for flavonoids 69 
25. Graphical representation showing extract curves for flavonoids 69 
26. Graphical representation showing standard curves for phenolic 
compounds. 
70 
27. Graphical representation showing extract curves for phenolic 
compounds. 
70 
28 TLC of extract at saponin solvent system 74 
29. TLC of extract at flavonoid solvent system 74 
30. HPTLC finger print data 75 
31 Graphical representation of HPTLC finger print analysis of extract 75 
32. Graphical representation of HECS herbal capsule for flavonoids 81 
33 Graphical representation of HECS herbal capsule for phenolic 
compounds 
82 
34. Graphical representation of change in body weight 84 
35. Graphical representation of lipid profile 86 
36. Graphical representation of AI 87 
37. Graphical representation of liver function test 88 
38. Histopathology of liver 89 
39. Histopathology of aorta 90 
 
                                                                              INTRODUCTION 
 
DEPT. OF PHARMACOGNOSY, COP, CH-03 Page 1 
 
INTRODUCTION 
CORONARY ARTERY DISEASE1-3 
Coronary artery disease (CAD), also known as ischemic heart disease (IHD) is a group 
of diseases that includes: coronary occlusion (Atherosclerosis), Angina pectoris, myocardial 
infarction and sudden coronary death. It is within the group of cardiovascular diseases of which 
it is the most common type. It is reported that almost 12 million people die of CHD disease 
each year all over the world. 
Risk factors of CAD include: 
 High blood pressure 
 Diabetes 
 High blood cholesterol 
 Obesity 
 Lack of exercise 
 Smoking 
 Lack of exercise 
 Excessive alcohol 
 Depression  
CEREBRO VASCULAR ACCIDENT (CVA) 4, 5 
Brain receives blood from basilar artery and internal carotid artery. The obstruction of 
blood flow to the brain leading to permanent damage is called a cerebrovascular accident (CVA) 
or cerebral infarction (stroke). If the symptoms are only temporary, it is referred to as a 
Transient ischemic attack (TIA). Rupture of an artery within the brain (cerebral hemorrhage) is 
also called a stroke or cerebrovascular accident. Atherosclerosis (plaque in the arteries) is the 
leading cause of cerebral ischemia. 
 
Risk factors for cerebrovascular disease include smoking, coronary artery disease, 
hypertension, diabetes, hyperlipidemia, peripheral vascular disease, atrial fibrillation, carotid 
disease and valvular heart disease. 
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 Factors that may affect the rating of an applicant with a history of cerebrovascular accident 
include Current neurological residuals, hypertension, high cholesterol levels, and generalized 
atherosclerosis. 
  
 
                                                Fig. 1: CORONARY ARTERY DISEASE 
                     
                       
Fig 2: CEREBRO VASCULAR DISEASE 
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ATHEROSCLEROSIS6,7 
Atherosclerosis (also known as atherosclerotic vascular disease or ASVD) is a specific 
form of arteriosclerosis in which an artery wall thickens as a result of invasion and accumulation 
of white blood cells (WBCs) (foam cells) and proliferation of intimal smooth muscle cell 
creating a “fibro fatty plaque”.  
Atherosclerosis is therefore a syndrome affecting arterial blood vessels due to  a chronic 
inflammatory response of WBCs in the walls of arteries.  This is promoted by low-density 
lipoproteins (LDL-plasma proteins that carry cholesterol and triglycerides) without adequate 
removal of fats and cholesterol from the macrophages by functional high-density lipoproteins 
(HDL). It is commonly referred to as a “hardening” or furring of the arteries. It is caused by 
the formation of multiple sclerosis.   
 
 
                                                     Fig 3 : Atherosclerosis  
 
 
 
     ATHEROSCLEROSIS 
ARTERY WITH PLAQUE         
FORMATION 
                   NORMAL ARTERY 
                                                                              INTRODUCTION 
 
DEPT. OF PHARMACOGNOSY, COP, CH-03 Page 4 
 
LIPIDS 8, 9 
It is the scientific quantitative term for fats in the blood. They are carried from one place to 
another by mixing with protein particles called Lipoproteins. Lipoproteins are divided into five 
major classes according to density such as 
 Chylomicrons 
 Very low density lipoproteins(VLDL) 
 Intermediate density lipoprotein(IDL) 
 Low density lipoprotein(LDL)(Bad cholesterol) 
 High density lipoprotein(HDL)(Good cholesterol) 
                           
                                     Table 1:  Normal levels of lipids 
Types Desirable 
mg/dL 
Cholesterol       < 200 
LDL Cholesterol       < 130 
HDL Cholesterol       ≥60 
Triglycerides       < 200 
 
HYPERLIPIDEMIA AND OBESITY10, 11 
       Hyperlipidemia is one of the greatest risk factors which further lead to coronary heart 
diseases, stroke, atherosclerosis and ischemic heart diseases, which are the primary cause of 
death. Hyperlipidemia is a condition characterized by elevation of one or more lipids including 
cholesterol, cholesterol esters, phospholipids and triglycerides in the blood stream. It is also 
called as hyperlipoprotenemia, because these fatty substances travel in the blood attached to 
protein. Central to the pathogenesis of atherosclerosis is deposition of cholesterol in the arterial 
wall. Nearly all lipoproteins are involved in this process including cholesterol carried by very 
low density lipoproteins (VLDL), low density lipoproteins (LDL) and remnant lipoproteins. 
Hyperlipidaemia results in metabolic syndrome which is characterized by obesity, Insulin 
resistance and endothelial cell dysfunction which ultimately ends in Hypertension, Diabetes 
(or) Stroke. 
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  Obesity is regarded as a social problem, associated with serious health risks and 
increased mortality. Obesity is difficult to define in quantitative term. It refers to the above 
average amount of fat contained in the body this in turn is dependent on the lipid content of 
each fat cell and on the total number of fat cells. WHO says obesity is related to cardiovascular 
disease, hypertension, diabetes mellitus, cancer, osteoarthritis, pulmonary diseases, as 
well as psychological issues, including social bias, prejudice discrimination and over eating. 
  According to WHO more than half of the total mortalities are associated with cardio 
vascular diseases. It is estimated that 12 million deaths per year occur from cardiovascular 
diseases, while one million of death in the European country occur due to obesity per year. 
                                              Table 2: Normal and abnormal levels of Lipids 
 
 
 
           
                                                                                            
  Fig 4: bad vs good cholesterol                                         Fig 5: obesity       
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Currently available synthetic drugs for hyperlipidemia and obesity8,12 
 
The consumption of synthetic drugs leads to hyperuricemia, diarrhoea, nausea, myositis, 
gastric irritation, flushing, dry skin   and   abnormal liver function. Though drugs therapies 
available for the treatment of hyperlipidemia includes use of drugs like Niacin, Fibrates 
(clofibrate, gemfibrozil), HMG-CoA reductase inhibitors (lovastatin, pravastatin, simvastatin 
and fluvastatin), Bile acid binding resins (cholestyramine and cholestipol) and Probucol but 
associated with lots of side effects. 
Orlistat, Lorcaserin, Sibutramine, Rimonabant, Metformin, Exenatide ,Pramlintide and  
some other anti-obesity drug therapies available for the treatment of obesity with lots of side 
effects.  
 
HERBAL MEDICINE13, 14 
Herbal Medicine sometimes referred to as Herbalism or Botanical Medicine, is the use 
of herbs for their therapeutic or medicinal value. An herb is a plant or plant part valued for its 
medicinal, aromatic or savoury qualities. Herb plants produce and contain a variety of chemical 
substances that act upon the body. 
Herbal medicine is the oldest form of healthcare known to mankind. Herbs had been 
used by all cultures throughout history. It was an integral part of the development of modern 
civilization. Much of the medicinal use of plants seems to have been developed through 
observations of wild animals, and by trial and error. As time went on, each tribe added the 
medicinal power of herbs in their area to its knowledgebase. They methodically collected 
information on herbs and developed well-defined herbal pharmacopoeias. Indeed, well into the 
20th century much of the pharmacopoeia of scientific medicine was derived from the herbal 
lore of native peoples. Many drugs commonly used today are of herbal origin. Indeed, about 25 
% of the prescription drugs dispensed in the United States contain at least one active ingredient 
derived from plant material. Some are made from plant extracts; others are synthesized to mimic 
a natural plant compound. 
The World Health Organization (WHO) estimates that 4 billion people, 80 % of the 
world population, presently use herbal medicine for some aspect of primary health care. Herbal 
medicine is a major component in all indigenous peoples’ traditional medicine and a common 
element in Ayurvedic, homeopathic, naturopathic, traditional oriental, and Native American 
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Indian medicine. WHO notes that of 119 plant-derived pharmaceutical medicines, about 74 % 
are used in modern medicine in ways that correlated directly with their traditional uses as plant 
medicines by native cultures. Major pharmaceutical companies are currently conducting 
extensive research on plant materials gathered from the rain forests and other places for their 
potential medicinal value.   
Some common herbs with hypolipidemic and obesity activity15 
 
It has been reported that traditional systems have immune potential against various 
diseases.  More than thirteen thousand plants have been studied for various pharmacological 
properties. An herbal treatment for hyperlipidemia and obesity has no side effects and is 
relatively cheap, locally available.  
               
                          Table 3:  Herbs with hypolipidemic and Anti-obesity activity 
 
s.no Plant name Family Part used Active constituent 
1 Achyranthus aspera Amaranthaceae Whole plant Achyranthine 
Achyranthol 
2 Bauhinia purpurea Caesalpiniaceae Leaf Bio-flavonoids 
3 Cinnamomum tamala Lauraceae Leaf Eugenol  
Methyl eugenol 
Volatile oil 
4 Cissus quandrangularis Vitaceae Stem Anabolic 
phytosterol 
5 Commiphora mukul  
 
Burseraceae Resin Guggle sterol 
6 *Garcinia cambogia Guttiferae/Clusiaceae Peel of matured 
fruits 
L-Hydroxy citric 
acid 
7 Gymnema sylvestre Asclepiadaceae Leaf Gymnemic acid 
8 Sapindus emarginatus Sapindaceae Pericarp Saponins 
9 Solanum melongena   Solanaceae Ripe fruit Solanine 
Solanosterol  
Steroidal 
sapogenin 
10 Terminalia arjuna Combretaceae Bark Arjunolic acid 
 
The present work is an attempt to determine the hypolipidemic and anti-obesity activity 
of Caesalpinia sappan heartwood. This plant has a folklore claim in the treatment of 
hyprecholesteremia but no studies have been reported so far. 
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2. REVIEW OF LITERATURE 
       Pharmacognostical Review 
1. Shrishailappa Badami et al (2003) carried out Pharmacognostical Evaluation of Caesalpinia sappan 
Heartwood16.   
2.  Mehrotra, S. and H.P. Sharma (1984) carried out Pharmacognostic studies on sappan (caesalpinia-
sappan linn) and its market samples17. 
 
       Phytochemical Review 
3. Zhao, M.-B et al (2014) isolated two new Phenolic compounds and  a new minor homoisoflavonoid 
from the Heartwood of  Caesalpinia sappan18. 
4. Zhang,J.-Y et al (2012)  isolated two new cassane diterpenoids from the seeds of Caesalpinia sappan 
Linn19 . 
5. Shu , S-H et al (2011)  studied about two novel biphenyl dimers from the heartwood of Caesalpinia 
sappan 20 . 
6. Fuke, C et al (1985)   isolated   2 aromatic-compounds related to brazilin from caesalpinia-sappan21. 
7. Nigam , S.S et al (1977)  carried out the Chemical examination on the heart wood of caesalpinia-
sappan22 
Pharmacological Review 
8. Kim, S.-H et al (2015)  reported  that Brazilin Isolated from Caesalpinia sappan Suppresses Nuclear 
Envelope Reassembly by Inhibiting Barrier-to-Auto integration Factor Phosphorylation23. 
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9. Nirmal et al (2014) reported the Anti-Propionibacterium acnes assay-guided purification of brazilin 
and preparation of brazilin rich extract from Caesalpinia sappan heartwood and then Wound healing 
activity of standardized brazilin rich extract24. 
10. Zhang et al. (2010) reported the Study of caesalpinia sappan aqueous extract's apoptosis-inducing 
effects on human ovarian cancer cell SKOV325 
11. Yodsaoue  et al. (2009) reported the  Anti-Allergic Activity of Principles from the Roots and 
Heartwood of Caesalpinia sappan on Antigen-Induced beta-hexosaminidase Release26 
12. Hemalatha K et al (2007) reported the Anti-inflammatory and analgesic activity of Caesalpinia 
sappan heartwood27. 
13. Chun , H et al(2002)  reported  the inhibitory effects of butyl alcohol extract from Caesalpinia sappan 
L. on melanogenesis in Melan-a cells28  
14. Xie, Y.W et al (2000)   studied the Vasorelaxing effects of Caesalpinia sappan - Involvement of 
endogenous nitric oxide29 
15. Hikino, H et al (1977) reported the  antiinflammatory  principles of Caesalpinia-sappan wood and of 
hematoxylon-campechianum  wood30. 
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3. ETHANOBOTANICAL SURVEY 31-35 
PLANT PROFILE   
 Plant name   : Caesalpinia sappan Linn                           
 Common name  : Sappan wood/ Brazil wood  
              Synonym   :  Binacaea  sappan  
                   / Caesalpinia minutiflora   
 Family :  Caesalpiniaceae /Fabaceae  
 
VERNACULAR NAMES 
 Tamil      :  Parthangi  
 English                               : Brazilwood  
 Malayalam                         :   Sappanam  
 Kanadam                            :    Patang  
 Telugu                                 :    Bakamu  
 Hindi                                   :     Patang  
 Gujarati                     :     Bakam  
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 TAXONOMICAL STATUS 
    Kingdom                                  :  Plantae                       
    Subkingdom :  Viridiplantae 
    Infra kingdom :  Streptophyta  
    Division :  Tracheophyta 
    Sub division :  Spermatophyta 
    Class : Magnoliopsida 
    Super Order                           : Rosanae 
    Order : Fabales 
    Family                  : Caesalpiniaceae/ Fabaceae 
                          Genus  : Caesalpinia Linn. 
     Species  : Caesalpinia sappan Linn- Sappan wood 
Geographical distribution 
Caesalpinia sappan plant is cultivated wild in tropical countries, locally abundant 
throughout the Philippines at low and medium altitudes. 
  Also occurs in India through Burma, Thailand Indo-China, southern China to 
Malaysia. 
In India, it is found in west Bengal, Madhya Pradesh, Orissa. 
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Habit 
               Caesalpinia sappan plant enjoys the open altitude of 1000m above sea level and 
grows well in mountainous areas that are not too cold.      
  It is small shaped leguminous tree, 5-10m high; 15-25cm diameter with spiny trunk. 
Morphology  
                  Leaves are compound, up to 50 centimeters long. Pinnae are about 20, opposite, 
and 10 to 20 centimeters long. Leaflets are 20 to 30, obliquely oblong to oblong-rhomboid. 
                  Flowers are yellow, on terminal panicles, 2 to 2.5 centimeters in diameter with 
densely wooly filaments. 
                  Fruit is a hard, indehiscent, shiny pod, about 7 centimeters long, and 3.5 to 4 
centimeters wide, with a hard recurved beak at the upper angle with seeds 3-4. 
                  Wood has outer sapwood which is white pale buff colour and inner orange red 
heartwood. 
Part used 
                  Heartwood. 
Chemical constituents 
                  The plant contains wide varieties of compounds, viz: triterpenoids, flavanoids,  
      Steroids, Oxygen heterocycles and aminoacids.        
o Tannin is found in the leaves 19%, bark and fruit walls 44%, pods 40%. 
o Leaves yield volatile oil, 0.16 to 0.25%; d-a-phellandrene, terpene, and methyl alcohol 
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o Stem yields a gum. 
o Brazilin, the main constituent of plant is oxidised to produce Brazilein by air and light 
 additional constituents include gallic and tannic acids. 
• Decoction of wood and bark used for tuberculosis, atonic diarrhoea, dysentery, wounds, 
 postpartum Tonic, skin infections,  ulcers, and anaemia. 
• Heartwood used against inflammation, diuretics. 
• Roots, stems and seeds used as sedative and vulnerary. 
• In Ayurveda, Heartwood useful in vitiated conditions of Pitta, burning sensations, wounds,  
Ulcers,leprosy, skin diseases, diarrhoea, dysentery, and diabetes. 
• In Kerala, decoction of heartwood used for blood purifying, anti-thirst, and anti-diabetic. 
 
Other uses 
o Cancer 
o Inhibition of melanocytes formation 
o Immunomodulatory  
o Hyperlipidemia  
o Liver disorder  
o Dye wood   
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BIOGRAPHY OF THE PLANT 
 
                                               Fig 6: Caesalpinia sappan whole plant view 
 
Fig 7:Caesalpinia sappan plant                          Fig 8 :Caesalpinia sappan  spiny trunk 
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Fig 9: Caesalpinia sappan  pods                    Fig 10: Caesalpinia sappan  flowers 
 
                                               
                                        Fig 11: Heartwood of Caesalpinia sappan 
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                                                    4. RATIONALE FOR SELECTION 
 
                
 Cardiovascular disease (CVD), particularly coronary heart disease (CHD) and 
cerebro vascular accident (CVA) is the leading cause of medically certified death 
in both developed as well as developing countries.  
 
 Hyperlipidemia and obesity is one of the greatest risk factors in the manifestation 
and development of CHD and CVA.  
 
 
 Medicinal plants have been shown to play a major role in treating hyperlipidemia 
and obesity and considering this, the present study was designed to develop an 
herbal capsules formulation on heartwood of Caesalpinia sappan for 
hypolipidemic and anti-obesity activity. 
 
 The plant Caesalpinia sappan Linn., belonging to the family Caesalpiniaceae was 
selected for the present work. 
 
 The Ethanomedicinal uses claimed were tuberculosis, atonic diarrhoea, 
dysentery, wounds, postpartum Tonic, skin infections, ulcers, anaemia, 
inflammation, diuretics. 
 
 No pharmacognostical work has been carried out on microscopical evaluation on 
the heartwood of Caesalpinia sappan . 
 
 The hypolipidemic and anti -obesity activity was not scientifically validated. 
 
 So the heartwood of the plant Caesalpinia sappan Linn., was selected for 
evaluation of  hypolipidemic and anti-obesity activity. 
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5. AIM AND OBJECTIVES 
 
 The objective of the study is to explore the Pharmacognostical, Phytochemical, Formulation and then 
Hypolipidemic and Anti-obesity Evaluation of herbal capsule on the Heartwood of Caesalpinia sappan 
Linn.,  
 
 Collection and Authentication of the plant specimen. 
 
 Establishing Pharmacognostical profile of the plant. 
 
 Extraction of plant material by using, cold maceration with solvents Ethanol and water (1:1) 
 
 Phytochemical screening and determination of bioactive constituents. 
   
 Formulation and evaluation of Herbal capsules. 
 
 Evaluation of Hypolipidemic and Anti- obesity activity by In-vivo models. 
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                                                      6. PLAN OF WORK 
 
I. PHARMACOGNOSTICAL STUDIES 
 
 Collection of plant material 
 Authentication 
 Macroscopy 
 Microscopy 
 Powder microscopy 
 Physiochemical constants determination 
 Qualitative analysis of heavy metals and inorganic elements 
 Quantitative estimation of heavy metals and inorganic elements. 
 
II. PHYTOCHEMICAL STUDIES 
 
 Preparation of Hydro-alcoholic extract(1:1) 
 Preliminary Phytochemical screening of powder and extract 
 Fluorescence analysis of powder and extract 
 Quantitative estimation of phytoconstituents. 
 Thin layer chromatography of extract. 
 High Performance Thin Layer Chromatography of extract. 
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III. FORMULATION OF HERBAL CAPSULE  
 
 Raw material standardization 
 Pre-formulation studies 
               (trial batches -3, optimizing for flow characteristics) 
 Formulation development and standardization 
 Accelerated stability studies 
               (at 400c and 75% RH for 3 months ) 
 
IV. PHARMACOLOGICAL STUDIES 
 
 Acute toxicity studies of formulated herbal capsule. 
 In vivo-Evaluation of Hypolipidemic and Anti-obesity activity.  
 
 High fat diet induced obesity in rats.  
 Measurement of body weight 
 Measurement of internal organs weight 
 Biochemical parameters 
 Atherogenic  index 
 Histopathological examination of rat aorta and liver. 
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7. MATERIALS AND METHODS 
7.1 PHARMACOGNOSTICAL STUDIES  
Collection of Plant Material 
The Heartwood of Caesalpinia sappan Linn., was collected from Kulasekaram 
in Kanyakumari district, Tamilnadu in June- 2015. 
Identification and Authentication of Plant Material 
The plant material was authenticated by Botanist Dr.V. Chelladurai, Research 
officer- Botany, Central Council for Research in Ayurveda and Siddha, Tirunelveli.  
The heartwood were shade dried, Coarsely powdered and used for further studies.  
7.1.1MACROSCOPY  
The plant materials are categorized according to sensory characteristics. 
Organoleptic evaluation provides the simplest and quickest means to establish the 
identity, purity and quality of a particular sample. Hence, this observation is of primary 
important before any further testing can be carried out. 
7.1.2 MICROSCOPY 36-47 
Staining method 
Fixation of plant material 
The sample or heartwood was cut fixed in FAA solution (Formalin 5ml + Acetic 
acid 5ml + 90ml of 70% Ethanol). The specimen was dehydrated after 24 hours of 
fixing. The heartwood were graded with series of tertiary butyl alcohol, as per the 
standard method. 
Infiltration of the specimen - It was carried out by gradual addition of 58 – 60º C of 
melting pointed paraffin wax until Tertiary butyl alcohol (TBA) solution attained super 
saturation. The specimens were cast into paraffin blocks. 
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Sectioning  
The paraffin embedded specimens were sectioned with the help of Rotary 
Microtome. The thickness of the sections was 10 - 12µ. Dewaxing of the sections were 
done by customary procedures. The sections were stained Toludine blue. Since toludine 
blue is a polychromatic stain, the sections were stained as per the method published by 
O’Breinet al.  The staining results were remarkably good. The dye rendered pink colour 
to the cellulose walls, blue to the lignified cells, dark green to subrein, violet to 
mucilage and blue to the protein bodies. Whenever  necessary sections were also stained 
with safranin, fast green and iodine for starch. 
PHOTO MICROGRAPHS 
Microscopic descriptions of tissues were supplemented with photo micrographs 
whenever necessary. Photographs of different magnifications were taken with Nikon 
lab photo 2 microscopic units. For normal observations bright field was used. 
For the study of crystals and lignified cells, polarized light was employed. Since, 
these structures have birefringent property under polarized light they appear bright 
against dark background. Descriptive terms of the anatomical features are as given in 
the standard anatomy books. 
POWDER MICROSCOPY 
The shade dried, powdered plant material was used for powder microscopic 
analysis. The organoleptic characters were observed and to identify the different 
characteristic features various staining reagent were used. Powder was stained with 1% 
phloroglucinol in 90% ethanol, concentrated hydrochloric acid and observed through 
microscope. All the lignified cells stained with pink colour. 
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7.1.3 PHYSIO – CHEMICAL EVALUATION 48-52 
Shade dried powdered plant material of heartwoods of Caesalpinia sappan 
Linn., was used for the determination of physio chemical constants in accordance with 
WHO guidelines. 
DETERMINATION OF ASH VALUES  
Ash values are helpful in determining the quality and purity of a crude drug in 
the powdered form. The residue remaining left after incineration of the crude drug is 
designated as ash. The residue obtained usually represents the inorganic salts naturally 
occurring in the drug and adhering to it. An ash value determination furnishes the basis 
for judging the identity and cleanliness of any drug and gives information relative to its 
adulteration/contamination with inorganic matter. 
TOTAL ASH  
The determination of ash is useful for detecting low grade products, exhausted 
drugs & excess of sandy and earthy material. Total ash is useful to exclude drugs which 
have been coated with chalk, lime or calcium sulphate to improve their appearance. The 
total ash usually consists of carbonates, phosphates, silicates and silica which include 
both physiological ash, which is derived from plant tissue itself and non-physiological 
ash which is the residue of the extraneous matter adhering to the plant surface. 
Procedure  
About 2-3 gm of the ground material was weighed accurately into previously 
ignited tared crucible, incinerated at a temperature not exceeding 4500c until free from 
carbon. The charred mass was  cooled in desicattor and weighed. The mass was 
exhausted with charred mass with hot water. The residue was collected on ashless filter 
paper and incinerated at a temperature not exceeding 4500c. Then the content of total 
ash in mg/gm of air -dried material.   
                                                          % Total ash value 
Wt. of total ash=               _______________________________X 100 
                                                       Wt. of crude drug taken 
 
                           MATERIALS AND METHODS 
 
DEPARTMENT OF PHARMACOGNOSY, COP, MMC, CH-03 Page 23 
 
Water soluble ash 
The ash was boiled for 5min with 25ml of water. The insoluble matter was then 
collected in an ash less filter paper. It was washed with hot water and ignited for 15min 
at a temperature not exceeding 450°c. The weight of the insoluble matter was subtracted 
from the weight of the ash and the difference in weight represented the water soluble 
ash, the percentage of water soluble ash with reference to the air dried substances was 
calculated by the formula. 
                                                    Wt. of total ash – Wt . of water insoluble ash 
        % Water soluble  ash value    =  ____________________________         X 100 
                                                                      Wt. of crude drug taken 
Acid insoluble ash  
Acid insoluble ash is the residue obtained after boiling the total ash with dilute 
hydrochloric acid, and igniting the remaining insoluble matter. This measures the 
amount of silica present, especially as sand and siliceous earth. Acid-insoluble ash is 
useful for detecting the presence of excessive earthy material. 
Procedure  
To the total ash obtained, 25ml of dilute hydrochloric acid was added, covered with a 
watch glass and boiled gently for 5min on a burner. The watch glass was rinsed with 
5ml of hot water and these washings were added to the crucible. The insoluble matter 
was collected on an ash less filter paper by filtration and the filter paper was rinsed 
repeatedly with hot water until the filtrate is neutral and free from acid. Filter paper 
containing the insoluble matter was transferred to the crucible, dried on a hot plate and 
ignited to a constant weight in the muffle furnace at 450-500°C. The silica crucible was 
removed from the muffle furnace and allowed to cool in a desiccator for 30min, and 
then weighed without delay. The content of acid insoluble ash was calculated. 
                   Wt . of water insoluble ash 
% Acid  insoluble  ash value =          Wt. of crude drug taken X 100 
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Sulphated ash 
2-3gm of air-dried substance was ignited gently at first in a crucible, until the 
substance was thoroughly charred. Then the residue was cooled, moistened with 1ml of  
sulphuric acid, heated gently until the white fumes were no longer evolved and ignited 
at 800±25°c, until all the black particles were disappeared. The crucible was allowed to 
cool, a few drops of sulphuric acid was added and heated. Then it was ignited as before, 
cooled and weighed. The percentage of sulphated ash with reference to the air- dried 
substance was then calculated.     
DETERMINATION OF EXTRACTIVE VALUES  
Extractive value gives idea about soluble chemical constituents in particular 
solvents. According to IP, alcohol, pet.ether and water soluble extractive values should 
be determined.  
Determination of water soluble extractive 
5gm of the powder was weighed and macerated with 100ml of chloroform water 
(95ml distilled water and 5ml chloroform) in a closed flask for 24 hours. It was shaken 
frequently for six hours and allowed to stand for eighteen hours. It was then filtered 
rapidly, taking precautions against loss of solvent and 25ml of the filtrate was 
evaporated to dryness in a tarred flat bottomed shallow dish. 2 ml of alcohol was added 
to the residue and it was dried at 105°C for 1 hour in the hot air oven and cooled in 
desiccators for 30min and weighed. The process was repeated till a constant weight was 
obtained; the percentage of water soluble extractive value with reference to the air dried 
drug was calculated. 
              
Water soluble extractive value        =          weight of the dried extract      X 100   
                                                                      weight of the sample taken 
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Determination of alcohol soluble extractive  
5gm of the powder was weighed and macerated with 100ml 90% ethanol in a 
closed flask for 24 hours. It was shaken frequently for six hours and allowed to stand 
for eighteen hours. It was then filtered rapidly, taking precautions against loss of solvent 
and 25ml of the filtrate was evaporated to dryness in a tarred flat bottomed shallow 
dish. It was dried at 105°C for 1hour in a hot air oven. The dish was cooled in desiccator 
and weighed. The process was repeated till the constant weight was obtained. The 
percentage of alcohol soluble extractive value with reference to the air dried drug was 
calculated. 
 
Alcohol  soluble extractive value         =           weight of the dried   extract    X 100   
                                                                           weight of the sample taken 
Determination of volatile ether soluble extractive 
2gm of powdered drug was accurately weighed and extracted with anhydrous 
diethyl ether in a continuous extractive apparatus for 20hours. The ether solution was 
transferred to tarred porcelain dish and evaporated spontaneously. Then it was dried 
over phosphorous pentoxide for 18hours and the total ether extract was weighed. The 
extract was heated gradually and dried at 105°C to constant weight. The loss in weight 
represents the volatile portion of the extract. 
Determination of moisture content (Loss on Drying)  
Specified quantity of the substances was taken in a previously ignited and 
cooled silica crucible and the substance was evenly distributed by gentle side wise 
shaking. The crucible with the contents was weighed accurately. The loaded crucible 
and the lid were placed in the drying chamber (105°C). The substance was heated for a 
specified period of time to a constant weight. The crucible was covered with the lid and 
allowed to cool in a desiccator at room temperature before weighing. Finally the 
crucible was weighed to calculate the loss on drying with reference to the air dried 
substance.   
% Loss on drying              =                           Loss in weight of the sample 
                                                                                                                          X 100 
                                                                             Weight of the sample 
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Determination of foaming index 
1gm of the coarsely powdered drug was weighed and transferred to 500ml 
conical flask containing 100ml boiling water. The flask was maintained at temperature 
80-90°C for about 30min. It was then cooled and filtered into a volumetric flask and 
sufficient water was added through the filtrate to make up the volume to 100ml. The 
decoction was poured into 10 stopper test tube (height 16cm, diameter 16mm) in 
successive portions of 1ml, 2ml, 3ml, 4ml up to 10ml and the volume of the liquid in 
each tube was adjusted with water to 10ml. The tubes were stoppered and shaked in a 
length wise motion for 15 seconds, two shakes per second. Allowed to stand for 15min 
and the height of the foam was measured. The results are assessed as follows. 
If the height of the foam in every tube is less than 1cm, the foaming index is 
less than   100. If a height of 1cm is measured in any tube, the volume of the plant 
material decoction in the tube (a) is used to determine the index. If this tube is the first 
or second tube in a series, prepare an intermediate dilution in a similar manner to obtain 
a more precise result. 
If the height of the foam is more than 1cm in every tube, the foaming index is 
over 1000. In this case repeat the determination using a new series of dilution of the 
decoction in order to obtain a result.Calculate the foaming index using the following 
formula: 
Foaming index = 1000/a 
Where, a = the volume in ml of the decoction used for preparing the dilution in the tube 
where foaming to a height of 1cm is observed. 
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Determination of swelling index  
The swelling index is the volume in ml occupied by the swelling of 1gm of plant 
material under specified conditions. A specified quantity of the plant material were 
previously reduced to the required fineness was accurately weighed and transferred into 
a 25ml glass stoppered measuring cylinder. The internal diameter of the cylinder should 
be about 16mm, the length of the graduated portion about 125mm, marked in 0.2ml 
divisions from 0 to 25ml in an upward direction. Unless otherwise indicated in the test 
procedure, add 25ml of water and shake the mixture thoroughly every 10min for 1hour, 
allowed to stand for 3 hours at room temperature. The volume in ml occupied by the 
plant material was measured including any sticky mucilage. Calculate the mean value 
of the individual determination, related to 1gm of plant material. 
Plant minerals play a vital role in metabolism. Presence of elements vary with 
the soil, climate conditions etc. There are essential and non-essential elements which 
may be beneficial or harmful to living things. Non essential elements like lead, arsenic, 
cyanide, chromium, cadmium, aluminium, silver bring about toxic effects resulting in 
intoxification. 
 
7.1.4 QUALITATIVE ESTIMATION OF INORGANIC ELEMENTS AND 
HEAVY METALS 
To the ash of the drug material 50%v/v hydrochloric acid was added and kept 
for 1 hour. It was filtered and the filtrate was used for the following tests. 
Aluminium: White gelatinous precipitate of aluminium hydroxide is formed on 
addition of ammonia solution. It is slightly soluble in excess of the reagent. The 
precipitate dissolves readily in strong acid and base, but after boiling it becomes 
insoluble.   
Arsenic:Arsenious salts in neutral solution react with solution of copper sulphate to 
form green precipitate (scheele’s green) which on boiling gives a red precipitate of 
cupric oxide. 
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Borate: The mixture obtained by the addition of sulpuric acid and alcohol (95%) to a 
borate when ignited, burns with flame tinged with green. 
Calcium: Solution of calcium salts, when treated with ammonium carbonate solution, 
yield a white precipitate after boiling and cooling the mixture (it is insoluble in 
ammonium chloride solution). 
Carbonate: Carbonate, when treated with dilute acid effervescence, liberating carbon 
dioxide which is colourless and produces a white precipitate in calcium hydroxide 
solution. 
Chlorides: Chlorides, when treated with silver nitrate solution, yield a white crude 
precipitate which is insoluble in nitric acid, but soluble after being well washed with 
water, in diluted ammonia, from which it is re precipitated by the addition of nitric acid. 
Copper: An excess of ammonia, added to a solution of a cupric salt, produces first a 
bluish precipitate and then a deep blue coloured solution. 
Iron: Solution of ferric salts, when treated with potassium ferrocyanide solution, yields 
an intense blue precipitate which is insoluble in dilute Hcl. 
Lead: Strong solution of lead salts, when treated with HCL, yield a white precipitate. 
Which is soluble in boiling water and is re deposited as crystals when the solution is 
cooled. 
Magnesium: Solution of magnesium salts, when treated with ammonium carbonate 
solution and boiled, yield a white precipitate, but yield no precipitate in the presence of 
ammonium chloride solution. 
Mercury: Solution of mercury salts, when treated with sodium hydroxide solution, 
yields a yellow precipitate. 
Nitrate: With solution of ferrous sulphate no brown colour was observed but if 
sulphuric acid is added (slow from the side of the test tube), a brown colour is produced 
at the junction of two liquids, indicating the presence of nitrates. 
Phosphate: Solution of phosphate when treated with silver nitrate with dilute ammonia 
solution and in dilute nitric acid yield yellow precipitate of normal silver ortho 
phosphate (distinction from meta and pyrophosphate) solution. 
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Potassium: Moderately strong potassium salts, which have been previously ignited to 
remove ammonium salts, when treated with perchloric acid (60%) yield a white 
crystalline precipitate. 
Silver: Solution of silver salts, when treated with potassium iodide solution yield a 
cream coloured precipitate which is insoluble in dilute ammonia solution and in nitric 
acid. 
Sulphates: Solution of sulphates, when treated with lead acetate solution yields a white 
precipitate which is insoluble in ammonium acetate solution and in sodium hydroxide. 
7.1.5 QUANTITATIVE ESTIMATION OF INORGANIC ELEMENTS 
Inductive coupled plasma-Optical emission spectroscopy (ICP-OES)  
It is an excellent multi-element technique with relatively good sensitivity and 
selectivity when configured correctly. This technique utilizes the plasma as an ion 
source or light emission source are capable of producing values. 
QUANTITATIVE ANALYSIS OF HEAVY METALS 
Instrumentation parameters:  
Instrument name: Inductive coupled plasma-Optical emission spectroscopy 
Instrument Model: PE Optima 5300DV ICP-OES; Optical system Dual view-axial or 
radial 
Detector system: Charge coupled detector, (UV-Visible detector which is maintaining 
at -40ºC) to detect the intensity of the emission line. 
Light source (Torch): Positioned horizontally in the sample compartment along the 
central axis of the spectrometer optics. Changing from axial to radial viewing is a 
simple software command and is accomplished by computer control of a mirror located 
in the optical path. The torch assembly of this system comprises of two concentric 
quartz tubes. 
Standard alumina injector: 2.0mm inner diameter.  
Spray chamber: Scott type 
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Nebulizer: Cross flow gem tip. 
Preparation of sample by acid digestion method: 50mg of powder was treated with 
acid mixture of sulphuric acid: water in the ratio of 4:1in the Kjeldahl flask and heated 
continuously till the solution is colourless. The sample mixture was then transferred in 
a 25ml volumetric flask and made up to the volume with distilled water. Blank solution 
was prepared as above without sample. 
The standards of Arsenic, Lead, Mercury and Cadmium were prepared as per the 
protocol and the calibration curve was developed for each of them. 
Detection: 
Samples were analyzed for the detection and quantification of the aluminium,  calcium, 
chloride ,borate, silver, copper, potassium, magnesium, iron by Inductively Coupled 
Plasma Emission Spectrometry. 
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7.2 PHYTOCHEMICAL STUDIES 
Phytochemical evaluation is used to determine the nature of phyto constituents 
present in the plant by using suitable chemical tests. It is essential to study the 
pharmacological activities of the plant. It can be done by confirmation with different 
chromatographic techniques like TLC ,HPLC and HPTLC. Therefore a complete 
investigation is required to characterize the Phyto constituents qualitatively and 
quantitatively. 
7.2.1Preparation of Extracts 53 
About 200gm of coarsely pulverized heartwood was taken in a closed bottle and 
it was defatted with petroleum ether. The defatting was continued for 9-10 days with 
occasional shaking. The petroleum ether extract was filtered. The marc left after 
petroleum ether defatting was taken out and dried under shade to get a dry mass, then 
extracted with ethanol and water(50:50) by using cold maceration extraction. The 
extraction was continued for 9-10 days with occasional shaking. The hydro alcoholic 
extract was filtered, concentrated under reduced pressure to a semisolid mass and was 
made free from solvent. The final obtained extract was weighed; percentage yield was 
calculated and stored in a cool place. Extraction is the preliminary step involved in the 
phytochemical studies. It brings out the metabolites into the extracting solvent depends 
upon its polarity. 
Extraction 
The percentage yield, colour and consistency of the extract were recorded and 
preceded for further detailed phyto chemical and pharmacological screening. 
7.2.2 PRELIMINARY PHYTOCHEMICAL SCREENING54-60 
The chemical tests for various Phyto constituents in the dried powder and 
extracts on heartwood of Caesalpinia sappan.,were carried out as described below and 
the results were recorded. 
Test for  Alkaloids 
Small quantity of the extract was treated with few drops of diluted hydrochloric 
acid and filtered. The filtrate was used for the followings, 
                           MATERIALS AND METHODS 
 
DEPARTMENT OF PHARMACOGNOSY, COP, MMC, CH-03 Page 32 
 
a)Mayer’s reagent (Potassium mercuric iodide solution) 
Alkaloids give cream colour precipitate with mayer’s reagent. 
b)Dragendorff’s reagent (Potassium bismuth iodide solution) 
     Alkaloids give reddish brown precipitate with  Dragendorff’s reagent. 
c) Hager’s reagent (Saturated solution of picric acid) 
Alkaloids give yellow coloured precipitates with Hager’s reagent. 
d) Wagner’s reagent (Solution of iodine in potassium iodide) 
Alkaloids give reddish brown precipitate with wagner’s reagent. 
Detection of Proteins 
Biuret test:The sample was treated with 5-8 drops of 10% w/w copper sulphate 
solution, violet color is formed. 
 
Detection of Flavonoids 
a) Shinodatest :Small quantity was dissolved in alcohol to this pieces to magnesium 
followed by concentrated hydrochloric acid were added dropwise and heated. 
Appearance of magenta colour shows the presence of flavonoids. 
 
b) With aqueous sodium hydroxide solution:Small quantity of the extract was 
dissolved in aqueous sodium hydroxide and appearance of yellow colour indicates the 
presence of flavonoids. 
 
Detection of Tannins 
a) Lead acetate test :The test solution was mixed with basic lead acetate 
solution and examined for formation of a white precipitate. 
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b) Ferric chloride test :A few drops of 5% aqueous ferric chloride solution 
was added to 2ml of an aqueous extract of the drug and examined for the 
appearance of bluish black color. 
Detection of fixed oils and fats: 
a)  Spot test :Small quantities of extracts were pressed between two filter 
papers. An oily stain on filter paper indicates the presence of fixed oils and fats. 
b)   Saponification test:Few drops of 0.5 % alcoholic potassium hydroxide 
were added to a small quantity of various extracts along with a drop of 
phenolphthalein. The mixture was  heated on the water bath for 1-2 hr . 
Formation of soap with the alkali indicates the presence of fixed oils and 
fats. 
Detection of Glycosides 
a)   Borntrager’stest:The powdered material was boiled with 1ml of sulphuric 
acid in a test tube for five minutes. Filtered while hot, cooled and shaken with equal 
volume of chloroform. The lower layer of solvent was separated and shaken with half 
of its volume of dilute ammonia. A rose pink to red colour is produced in the ammonical 
layer. 
b)  Modified Borntrager’stest :The test material was boiled with 2ml of the 
dilute sulphuric acid. This was treated with 2ml of 5% aqueous ferric 
chloride solution (freshly prepared) for 5 minutes, and shaken with equal 
volume of chloroform. The lower layer of solvent was separated and 
shaken with half of its volume of dilute ammonia. A rose pink to red colour 
is produced in the ammonical layer. 
Detection of Steroids and Triterpenoids 
a) LibermannBurchardsTest :The powdered drug was treated with few 
drops of acetic anhydride, boiled and cooled. Conc.sulphuric acid was 
added from the sides of the test tube, brown ring is formed at the junction 
of two layers and upper layer turns green which shows presence of steroids 
and formation of deep red color indicates presence of tri terpenoids. 
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b)Salkowski Test:The extract was treated with few drops of concentrated 
sulphuric acid, red color at lower layer indicates presence of steroids and 
formation of yellow colored lower layer indicates presence of tri 
terpenoids. 
Detection of Carbohydrates 
a) Molisch’s test:To the test solution few drops of alcoholic alpha napthol 
and few drops of conc. sulphuric acid were added through the sides of test 
tube, purple to violet color ring appears at junction. 
b)Fehling’s test :The test solution was mixed with Fehling’s I and II and 
heated and examined for the appearance of red coloration for the presence 
of sugar. 
Detection of Saponins:A drop of sodium bicarbonate solution was added to the sample 
and the mixture was shaken vigorously and left for 3 minutes. Development of any 
honey comb like froth was examined. 
7.2.3 FLUORESCENCE ANALYSIS 61, 62 
Many crude drug show the Fluorescence when the sample is exposed to UV 
radiation. Evaluation of crude drugs based on fluorescence in day light is not much 
used, as it is usually unreliable due to the weakness of the fluorescent effect. 
Fluorescent lamps are fitted with suitable filter, which eliminate visible radiation from 
the lamp and transmits UV radiation of definite wavelength. Several crude drugs show 
characteristic fluorescence useful for their evaluation. 
7.2.4 QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
TOTAL SAPONNIN CONTENT 63 
20 gm of the powder of Heartwood was put into a conical flask and 100ml of 
20% aqueous ethanol were added. The samples were heated ove r a hot water bath for 
4 hrs with continuous stirring at about 55ºC. The mixture was filtered and the residue 
re-extracted with another 200ml of 20% of ethanol. The combined extracts were 
reduced to 40 ml over water bath at about 90ºC. The concentrate was transferred into a 
250 ml separating funnel and 20ml diethyl ether was added and shaken vigorously. The 
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aqueous layer was recovered while the ether layer was discarded. The purification 
process was repeated.60 ml of n-butanol was added. The combined n-butanol extracts 
were washed twice with 10ml of aqueous sodium chloride. The remaining solution was 
heated in a water bath. After evaporation the samples were dried in the oven to a 
constant weight. The saponnin content was calculated as percentage. 
ESTIMATION OF FLAVONOIDS64: 
Method : HPLC 
Extraction solvent- Mixture of alcohol, water and HCl (50:20:8) 
Mobile phase- A mixture of methanol, water and phosphoric acid (100:100:1) 
Standard solutions- Accurately   weighed quantities of USP quercetin RS, Rutin, 
Gallic acid, Thymoquinone, Gallangin  to separate volumetric flasks, which is dissolved  
in methanol, and diluted quantitatively, and stepwise if necessary, with methanol to 
obtain standard solution 1 mg/ml, respectively. 
Test solution – About 10g of hydroalcoholic extract were weighed to a 250 ml 
flask fitted with a reflux condenser. 78ml of extraction solvent added and refluxed on a 
hot water bath for 135 minutes. Then it was allowed to cool at room temperature. 
Decanted to a 100 ml volumetric flask. Then 20ml of methanol added to 250 ml flask, 
sonicated for 30 minutes, filtered and the filtrate was collected in 100 ml volumetric 
flask, the residue was washed on the filter with methanol. Then the washing was 
collected in the same 100 ml volumetric flask, diluted to volume and mixed. 
Chromatographic system – The liquid chromatograph was equipped with a 270 
nm detector and a 4.6mm x 25 cm column that contains packing L1. The flow rate was 
about 1.5ml per minute. Chromatograph standard solution 1 and the peak reponses was 
recorded. 
Procedure – Separately injected equal volumes( about 20 µL) of each of the 
standard solution and the test solution into the chromatograph, chromatographs was 
recorded and areas were measured for the major peaks. The quantity of each flavonoids 
in sample was calculated and given. 
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ESTIMATION OF PHENOLIC CONTENT65 
Method : HPLC 
Column : C18  
Stationary phase: octadecylsilyl silica gel for chromatography R(5µm). 
Mobile phase :  glacial acetic acid R, tetrahydrofuran R, water R (2:5:40:60 v/v/v). 
Flow rate : 0.9mL/min 
Detection : spectrophotometer at 254nm 
Injection : 20 µL 
Run time : 30 min 
Standard  solution : Accurately   weighed quantities of USP phenol standard in 
tetrahydrofuran R and dilute to 10ml with the mobile phase.  
Then the quantitative amount of phenolic compounds present in both Caesalpinia 
sappan extract and herbal capsules were determined and reported. 
7.2.5 CHROMATOGRAPHY 66,67 
Chromatography methods are important analytical tool in the separation, 
identification and estimation of components present in the plant. 
Chromatographic fingerprinting has been in use for a long time for single chemical 
entity drug substances. Recently it has become one of the most powerful tools for 
quality control of herbal medicines. The use of chromatographic fingerprinting for 
herbal drugs tends to focus on identification and assessment of the stability of the 
chemical constituents observed by various chromatography techniques such as HPLC, 
TLC, HPTLC, GC, capillary electrophoresis. 
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THIN LAYER CHROMATOGRAPHY 
Principle 
Thin layer chromatography is a technique used for the separation, identification 
and estimation of single or mixture of components present in the various extracts. It is 
reliable technique in which solute undergoes distribution between two phases, 
stationary and mobile phase. The separation is mainly based on the differential 
migration that occurs when a solvent flows along the thin layer of stationary phase. This 
may be achieved by partition and adsorption depending on stationary phase used. 
TLC Plate Preparation 
The plates were prepared using Stahl TLC spreader. 40gm of silica gel G was 
mixed with 85ml of water to prepare homogenous suspension and poured in the 
spreader. 0.25mm thickness of plates was prepared, air dried until the transparency of 
the layer disappeared, then dried at 110°C for 30 minutes and kept in desiccators. 
 
Selection of mobile phase:   
Solvent mixture was selected on the basis of the phyto constituents present in 
each extract. Factors such as nature of components, stationary phase, mobile phase, 
polarity, influence the rate of separation of constituents. From the vast analysis, best 
solvent was selected which showed good separation with  
maximum number of components. 
 
The Retardation Factor (Rf) is calculated using following formula, 
                                                            
                                        Distance travelled by solute from the origin 
                       Rf   =      ____________________________________ 
 
Distance travelled by solvent from the origin 
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HPTLC FINGER PRINTING OF EXTRACT: 
HPTLC is one of the versatile chromatographic method which helps in the 
identification of compounds and thereby authentication of purity of herbal drugs. The 
time required in this method for the demonstration of most of the characteristic 
constituents of a drug is very quick and short. In addition to qualitative detection, 
HPTLC also provides semi- quantitative information on major active constituents of a 
drug, thus enabling an assessment of drug quality.   
Instrument Conditions: 
Instrument                    : CAMAG HPTLC 
HPTLC Applicator      : CAMAG LINOMAT IV 
HPTLC Scanner          : CAMAG TLC SCANNER II 
Sample                           : HYDROALCOHOLIC EXTRACT 
Volume of injection      : 20 µl  
Mobile phase                : Ethyl acetate : chloroform : methanol   (5.3:1.5:0.5) 
ƛ  max                           :  200-400 nm 
Lamp                            :  Deuterium 
 Stationary phase          : TLC Silica gel 60 F254 ( Merck)  
Equipment: 
A Camag HPTLC system equipped with a sample applicator Linomat IV, Twin trough 
plate development chamber, TLC Scanner II. 
 
Chromatographic conditions: 
The estimation has been done using the following chromatographic conditions. 
Chromatography was performed on a 12 × 3 cm (H x W) pre-activated HPTLC silicagel 
60 F254 plate. Samples were applied to the plate as 6mm wide band with an automatic 
TLC applicator Linomat IV with nitrogen flow (CAMAG, Switzerland), 8mm from the 
bottom. 
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Densitometric scanning was performed on CAMAG scanner II. The plates were pre-
washed with solvent ethyl acetate. 
HPTLC serves as a convenient tool for finding the distribution pattern of phyto 
constituents which is unique to each plant. The fingerprint obtained is suitable for 
monitoring the identity and purity of drugs and for detecting adulteration and 
substitution. HPTLC technique is helpful in order to check the identity, purity and 
standardize the quantity of active principles present in the herbal extract. 
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7.3 FORMULATION OF HERBAL CAPSULE 
Raw material used for formulation development was tested for its identity, 
purity and quality by relevant preliminary tests. Formulation development studies were 
optimized with three different batches. 
SAMPLING OF RAW MATERIALS68 
 From each container or package selected, three original samples were taken 
with care to avoid fragmentation. Samples were taken from the top, middle and bottom 
of the container. In the case of sacks and packages, the three samples were taken by 
hand, the first from a depth of not less than 10 cm from the top and the second and third 
from the middle and bottom after cutting into the side of the package. The three original 
samples were then combined into a pooled sample which was mixed carefully. The 
average sample was obtained by quartering the pooled sample. 
 
7.3.1 ANALYSIS OF RAW MATERIAL 
Raw materials were standardized as per WHO guidelines. 
For crude herbal drugs, determination of foreign organic matter, loss on drying, 
total ash, acid insoluble ash, water soluble ash, sulphated ash, water soluble extractive, 
alcohol soluble extractive ,ether soluble extractive, heavy metals analysis, microbial 
load analysis were analysed according to Ayurvedic Pharmacopoeial procedure.  
DETERMINATION OF FOREIGN ORGANIC  MATTER 69 
Procedure: 100g of the drug sample was weighed and then it was spread out in a thin 
layer. The foreign matter was detected by inspection with the use of a lens. Foreign 
matter found were separated and weighed and the percentage was calculated.    
     
            Foreign organic matter =          Weight of the sample after inspection     ×  100 
                                                                Weight of the sample before inspection                                                                         
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MICROBIAL LOAD ANALYSIS70 
Materials and Methods  
The following test is carried out for the estimation of number of viable aerobic 
microorganisms present and for detecting the presence of designated microbial 
species in the herbal medicines. 
Procedure  
1. Total aerobic viable counter  
2. Yeast and moulds 
3. Escherichia coli  
4. Salmonellae  
5. Pseudomonas 
6. Staphylococcus  
Procedure  
Pre-treatment of the herbal material  
The crude medicinal plant material or product was grinded and diluted with 
phosphate buffer pH 7.2 to eliminate any antimicrobial properties.  
Total aerobic viable count 
To one petri disk of 10cm in diameter, a mixture of 1 ml of the pre-treated plant 
material or product and 15cm of liquefied casein-soybean digest agar was added at 40o 
C. the material was diluted to obtain an expected colony count of more than 300. At 
least two dishes were prepared using the same dilution. they were inverted and 
incubated at 30-35o C for 72 hrs, unless a more reliable count was obtained in a shorter 
period of time. The number colonies formed was counted and result were calculated 
using the plate with the largest number of colonies, upto maximum of 300. 
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Total yeast and mould count  
 To one perti disk of 10cm in diameter , a mixture of 1 ml of the pre-treated 
plant material or product and 15cm of liquefied sabouraud glucose agar with antibiotic 
was added at 40oC. the material was diluted to obtain an expected colony count of more 
than 100.At least two dishes were prepared using the same dilution and they were 
incubated them upright at 20-25oC for five days , unless a more reliable count was 
obtained in a shorter period of time. The number colonies formed was counted and 
result were calculated using the plate with not more than 100 colonies. 
Escherichia coli  
1 ml of material was added to 100 ml of MacConkey broth and it was incubated 
at 43-45oC for 24 hrs. 
 A subculture was prepared an a plat with MacConkey agar medium and 
incubated at 43-45oC for 24 hrs. growth of red , generally non-mucoid colonies of Gram 
– negative road, sometime surrounded by a reddish zone of precipitation indicates the 
presence of  E.coli. 
Salmonella sp 
 The pre-treated plant material or product was incubated at 35-37oC for 5-24 
hours, as appropriate for enrichment. 
Primary test   
10 ml of the enriched culture was transferred to 100 ml tetrathionate bile 
brilliant green broth and was incubated at 42-43oC for 24 hours. Subcultures were 
prepared on to agar media and brilliant green agar. Then they were incubated at 35-
37oC for 24 hours. The well-developed colourless colonies in deoxycholate citrate agar 
medium and small, transparent and colourless or opaque, pink or white. 
 Pseudomonas aeruginosa 
1 ml of the prepared material was inoculated in 100 ml of soyaben-casein digest 
medium. Mixed and incubated at 35-37oC for 24 -48 hours. Prepared on a subculture 
on a plate of cetrimide agar and incubated at 35-37oC for 24 -48 hours. 
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If the no growth of microorganism is detected , the material passes the test. If 
growth of colonies of Gram-negative rods occurs, usually with a greenish fluorescence. 
Staphylococcus aureus 
Prepared material was incubated at 35-37oC for 24 -48 hours. The material 
passes the test if no growth of microorganism is detected. Black colonies of Gram-
positive cocci often surrounded by clear zones may indicate the presence of 
staphylococcus aureus.  
7.3.2PREFORMULATION STUDIES71 
       To formulate any dosage forms, it is essential that fundamental physical and 
chemical properties of the drug powder are to be determined.   
Definition:  
 Preformulation involves the application of biopharmaceutical principles to the 
physicochemical parameters of drug substance are characterized with the goal of 
designing Optimum drug delivery system. Before beginning the Preformulation 
programs the preformulation scientist must consider the following factors 
  The amount of drug available.  
 The physicochemical properties of the drug already known.  
 Therapeutic category and anticipated dose of compound.  
 The nature of information, a formulation should have or would like to have.   
SELECTION OF EXCIPIENTS72 
            For the formulation of capsules in addition to the active ingredients, excipients  
like diluents (filler), binder, disintegrating agent, lubricant and preservatives are 
required. The choice of excipients was made keeping in mind the current Food and 
Drugs Administration (FDA) regulations.  
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Diluents:  
  Diluents/Fillers are added where the quantity of active ingredient is less (or) 
difficult to filling. Common tablet/capsule filler include Lactose, Dicalcium phosphate, 
Microcrystalline cellulose, etc.  
Lubricants:  
They reduce friction during the filling process. In addition, they aid in 
preventing adherence of capsule material. Magnesium Stearate, Stearic acid, 
Hydrogenised vegetable oils and talc are commonly used lubricants. 
Glidants:  
  It is used to improve flow of the powder materials by reducing the friction 
between the particles. The most effective glidants are the Colloidal silicon dioxide, Talc 
and Starch.  
Preservatives:  
 The preservatives are added to herbal formulation to prevent contamination, 
deterioration and spoilage by bacteria, fungal and other microorganisms. The most 
effective preservatives are the sodium methyl paraben, sodium propyl paraben, sodium 
benzoate and bronopol. 
selection of excipients in the formulation are given below 
 Talc                                                       -glident/lubricant 
 Microcrystalline cellulose                    -diluent/disintegerant 
 Starch                                                   -binder/disintegerant 
 Colloidal sillicon dioxide                     -glident 
 Magnesium stearate                              - lubricant 
 Bronopol & sodium methyl paraben   -preservative 
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PREPARATION OF FORMULATION73-76 
  The dry hyroalcoholic extract of Caesalpinia sappan were dried in tray drier at 
60oc for 20 minutes. All excipients used in this formulation except preservatives were 
dried separately in tray drier at 100oc for 30 minutes. All active ingredients were 
weighed according to the formula, mixed and lubricated with magnesium stearate 
followed by diluents and preservatives were mixed well. The mixture was blended 
thoroughly for 30 minutes. Then the powder was transferred to the polythene bags and 
labelled for further studies. 
7.3.3DEVELOPMENT OF FORMULATION-TRIAL BATCHES 
    Three trial batches were formulated by varying the composition of the excipients 
proportions for excellent flow properties. 
 
                                            Table  4 : Development of formulation  
s.no Materials Trial-1 
(g) 
Trial-2 
(g) 
Trial-3 
(g) 
1 Caesalpinia sappan 
extract 
20 20 20 
2 Talc 1.7 1.8 2.5 
3 Mcc 0.8 0.9 1 
4 Starch 2 2.5 2.6 
5 Magnesium stearate 0.8 1 1.5 
6 Colloidal sillicon dioxide 0.25 0.28 0.3 
7 Bronopol 0.15 0.15 0.15 
8 Sodium methyl paraben 0.15 0.15 0.15 
 
 
Evaluation of blended powder 
The blended powder of all trial batches were analysed for its flow characteristics 
like bulk density, tap density, compressibility index, Hausner’s ratio and angle of 
repose.  
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Bulk density and  tap  density  and  Carr’s  index  
A  weighed  quantity  (15g)  of  powdered  material  was  taken  in  a  50ml  
measuring  cylinder.  And recorded the initial volume (vo).  tapped the  contents  and  
recorded  the powdered  volumes  after  50 taps(v50). 
Fluff density = w/vo g/cc 
Tapped density   = w/vο50 g/cc 
Carr’s index = Tapped density- Fluff density/ Tapped density * 100  
Value  for  Carr’s  index  below  15  indicate  excellent  flowing  material  and  value  
over  20-30 suggested poor  flowing  material. 
Angle of  repose 
A  funnel  was  fixed  at  a  particular  height  (1.5,  2.5,  3.5  cm)  on  a  burette  
stand.  A white  paper was  placed  below  the  funnel  on  the  table.  The  powdered  
drug  passed  slowly  through  the funnel until  it  forms  a  pile.  The radius of the pile 
was   noted down. 
Angle  of  repose  of   the  powder  material  was  calculated  by using  the  formula: 
tanθ = h/r 
 θ = tan (h/r) 
where, h = height of the pile, r = radius. 
Values  for  angle  of  repose  < 30ο  usually  indicate  a  free  flowing  material  and   
angle > 400 suggest a  poor  flowing  material.  
Hauser’s ratio  
The  basic  procedure  is  to  measure  the  unsettled  apparent  volume,  V0 and  
the  final  tap  volume Vf  ,  of  the  powder  tapping  the  material  until  no  further  
volume  changes  occur.   
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The  Hausner’s ratio was  calculated  as  follows:   
Hausner’s ratio = V0 / Vf  
Hausner’s ratio  between  1.00  to  1.11  shows  excellent  flow  and  value  more  than  
1.60  shows very poor flow. 
                                    Table 5:  Final batch composition -250 mg/capsule 
S.No Ingredients Quantity  in         mg 
1 Caesalpinia sappan 200 
2 Talc 25 
3 Colloidal sillicon dioxide 3.7 
4 Magnesium stearate 0.85 
5 Micro crystalline cellulose 12.5 
6 Starch  7.4 
7 Sodium methyl paraben 0.25 
8 Bronopol 0.25 
 
From the 3 trial batches one optimized batch is selected for formulation based on above 
results. Trial batch 3 was found to be the perfect batch and it was selected for the 
consideration of further large scale manufacturing. 
7.3.4 FORMULATION OF CAPSULES77-82 
Capsules are small dosage form in which one or more medicinal and inert 
ingredients are enclosed in a small shell usually made of gelatin.  
CAPSULE SIZE AND SELECTION OF FILLING METHOD 
       •The formulated granules were filled in “1” size capsules to an average net content         
t  weight of 270 mg. 
       •The capsules were then de dusted, transferred into polybags, labelled and the 
       Samples were evaluated as per the testing requirements.   
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       • After approval from QAD the capsules were packed as per the packing 
instructions.  
• A hand operated gelatin capsule filling machine (Chamunda pharm machinery) 
was used in this study for encapsulation of capsules. 
       • from the final trial, samples were taken for accelerated stability studies as per 
           the testing requirements.  
 
 
                                             Fig 12: HERBAL CAPSULE 
7.3.5 STANDARDISATION OF HERBAL CAPSULES83, 84 
               The developed herbal capsules were standardized for its description, 
uniformity of weight, disintegeration time, moisture content, physicochemical 
parameters, phytochemical studies, fluorescence analysis. Standardization were crried 
out as per Indian pharmacopoeial procedures.      
Quality control parameters 
Description  
  The general appearance of a capsule, its visual identity and overall “elegance” 
is essential for consumer acceptance. The color, shape, odor and surface texture are all 
noted for the capsules prepared.  
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Uniformity of weight 
20 individual units were selected at random and their content was weighed and 
their Average weight was calculated. Not more than two of the individual weights 
deviate from the average weight by more than the percentage shown in the table 
                                       Table: 6  Acceptance Criteria I.P Limit  
 
 
 
 
Disintegration test 
Disintegration test was performed using the digital microprocessor based 
disintegration  test apparatus  (Veego, Mumbai ).One  capsule  was  introduced  into  
each  tube  and  added  a  disc  to each  tube.  The  assembly  was  suspended in  the  
water  in  a  1000  ml  beaker.  The  volume of water was  such  that  the  wire  mesh  at  
its  highest  point is  at  least  25  mm  below  the  surface  of water,  and  at  its  lower  
point  was  at  least  25  mm  above  the bottom  of  the  beaker.  The apparatus was 
operated and maintained  the  temperature  at  37±2°C. (Indian Pharmacopoeia, 2010). 
Determination of moisture content   
The loss on drying test is important when the herbal substance is known to be 
Hygroscopic. An excess of water in medicinal plant materials will encourage Microbial 
growth, the presence of fungi, insects deterioration. In modern Pharmaceutical 
technology, the water content provides information concerning the Shelf life and 
quality of the drugs.  
 
                             Moisture content (%) =        Final weight of the sample  
                                                                         Initial weight of the sample      ×100  
  
Dosage 
form 
Average 
limit  
Deviation 
 
capsules 
< 300 mg 10% 
>300mg 7.5% 
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 pH  
  1 g of capsule powder was taken and dissolved in 100 ml demineralized water. 
The pH value of the solution was determined by means of a digital PH meter. The pH 
meter was calibrated using buffers of 4, 9 and 7 PH. The electrodes were immersed in 
the test solution and PH was measured. 
 
7.3.6 ACCELERATED STABILITY STUDIES OF THE CAPSULES85-87 
Definition   
  Stability is defined as the extent to which a product retains, within specified 
limits and throughout its period of storage and use (i.e., its shelf-life) the same 
properties and characteristics that it possessed at the time of its manufacture. 
Accelerated testing 
 Studies designed to increase the rate of chemical degradation or physical 
change of a drug substance or drug product by using exaggerated storage conditions as 
per of the formula stability studies. Date from the studies , in addition to long tern 
stability studies, can be used to assess longer term chemical effect at non acceleration 
and to evaluate the effect of short –term excursions outside the label store conditions 
such a might occurs during shipping. result from accelerated testing studies are not 
always predictive of physical changes.     
Conditions of Stability studies  
 Accelerated condition of 40° C ± 2° C / 75% RH ± 5% RH  
 Long term condition of 25° C ± 2° C / 60% RH ± 5 % RH  
 Long term / intermediate condition of 30° C ± 2° C / 75 % RH ± 5% RH   
The ICH Harmonized Tripartite Guideline provides a general indication on the 
requirements for stability testing of new drug substances and products. The main 
thrust of the stability guideline centers on criteria for setting up stability protocols.  
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Climatic zones:  
The four zones in the world that are distinguished by their characteristic 
prevalent annual climatic  
   
                     Table : 7  Climatic zones and derived storage conditions. 
ZONE CONDITION TEMPERATURE HUMIDITY 
Zone 1 Temperature                21ºc 45% RH 
Zone 2 
Sub-tropical with possible 
humidity 
               25ºc 60% RH 
Zone 3 Hot/ dry                30ºc 35% RH 
Zone 4 Hot / humid                40ºc 70% RH 
 
 
As our country comes under zone IV, the following conditions were maintained 
throughout the study 
Accelerated stability condition : Accelerated stability study were carried out of 
storage condition at 40° C ± 2° C  of humidity 70% RH for  3 month(time period 
covered). 
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7.4 PHARMACOLOGICAL STUDIES 
7.4.1. ACUTE TOXICITY STUDY (OECD 423 GUIDELINES) 88,89 
Animals were kept in the lab for one week to acclimatize to laboratory 
conditions before starting the experiment, they were allowed to free access of water and 
standard rat feed. 
Organization for Economic co-operation and development (OECD) regulates 
guideline for oral acute toxicity study. It is an International Organization which work 
with the aim of reducing both the number of animals and the level of pain associated 
with acute toxicity testing. Organization for Economic co-operation and development 
(OECD) regulates guideline for oral acute toxicity study. It is an International 
Organization which work with the aim of reducing both the number of animals and the 
level of pain associated with acute toxicity testing. 
Following are the main type of guideline followed by OECD 
Guideline 420, fixed dose procedure (5 animals used) 
Guide 423, Acute toxic class (3 Animals used) 
Guide 425, Up and Down method (1 Animal used) 
Toxicity – Acute toxic class method (OECD 423 GUIDELINES) 
The acute oral toxicity study was carried out as per the guidelines set by 
Organization for Economic Co-operation and Development (OECD), received from 
Committee for the Purpose of Control and Supervision of Experiments of Animals 
(CPCSEA), Ministry of Social justice and Empowerment, Government of India. 
The method is based on biometric evaluation with fixed doses (5,50,300 and 
2000 mg/kg b.w., p.o) and results allow the substance to be ranked and classified 
according to Globally Hormonised System (GHS) classification of extract which causes 
hypolipidemic and anti-obesity. 
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                                                  Fig 13 :  OECD guidelines 
 
Healthy female albino rats were selected and the animal were procured from the 
animal house of the Institution were used. Animals were divided into 2 groups of 
3animals each. The starting were deprived of diet for four hours and water was given 
ad libitum. The animals dose level 2000 mg/kg bw.,p.o of the extracts of tablet was 
administrated. 
The animals were kept under direct observation for first four hours and 
thereafter for 24 hours and were observed for mortality. The animals were then kept 
under observation for 14 days. 
Body weight of rats before and at the end of the  termination was observed and 
any changes in awareness, mood, motor activity , CNS excitation , Motor coordination, 
muscle tone , reflexes were noted. The onset of toxicity and signs of toxicity was also 
if any noted. 
There was no death as per the guidelines, so the study was repeated with the 
same dose to confirm the result. 
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The protocol for conducting the In Vivo study in either sex  of adult albino 
wistar rat was approved by the Institutional Ethical Committee (ICE) of the Madras 
Medical College, Chennai - 600003, India Approval no: Vide 14/243/CPCSEA. 
Dated :10.08.2015 
EXPERIMENTAL DESIGN90-92 
7.4.2 IN -VIVO EVALUATION OF HYPOLIPIDEMIC AND ANTI-OBESITY 
ACTIVITY (HIGH FAT INDUCED OBESITY IN RATS MODEL) 
Experimental animals 
 Thirty albino wistar rats of thirty  weighing 140-160 gm were randomly divided 
into 5 groups of six animals each and kept in their cages for 1 week prior dosing to 
allow for acclimatization to the laboratory conditions, with free access to food and 
water, ad libitum. The study was carried out after obtaining the Animal ethics 
committee (14/243/CPCSEA. Dated :10.08.2015). 
Chemicals 
 Cholesterol, coconut oil and Atorvastatin, chemicals used for the study were of 
analytical 
 grade. 
Dose selection 
 The content of HECS herbal capsules was found to be safe at the dose of 
2000mg/kg in the acute toxicity study. Hence for In-vivo evaluation, two doses of the 
hydro alcoholic extract of Caesalpinia sappan (HECS) herbal capsule were selected as 
200mg and 400mg/kg, p.o.  Atorvastatin was calculated based on a human dose of 1mg 
/kg, p.o. 
Experimental design 
 Rats were divided into five groups containing six animals each. The   schedule of 
grouping and treatment is given below in table 8 
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Table 8 :HIGH FAT DIET(HFD) INDUCED HYPERLIPIDEMIA AND 
OBESITY MODEL 
 
GROUP  NAME OF THE 
GROUP 
TREATMENT SCHEDULE 
Group 1  Normal control Normal food and vehicle p.o for 60 days 
Group 2 Disease control HFD  and vehicle p.o for 60 days 
Group 3 Standard control HFD and vehicle for p.o 60 days and 
atorvastatin 1mg/kg from 31-60th days. 
Group 4 Test group 1 HFD and vehicle for 60 days and HECS 
herbal capsule 200mg/kg p.o from 31-
60th days. 
Group 5 Test group 2 HFD and vehicle for 60 days and HECS 
herbal capsule 400mg/kg p.o from 31-
60th days. 
 
Hyperlipidaemia was induced by feeding a high fat diet that consists of 58% fat, 
25% protein and 17% carbohydrate , lard(13%), vitamins, minerals and cholesterol 
400mg/kg in coconut oil  to all healthy rats  except group 1(normal control rats)for 
60days.  
7.4.3 EVALUATION PARAMETERS 
A) Body weight     
  The body weight (g) was recorded on  day1, day 30 and day 60  using a digital 
weighing balance in each group animals. The changes in body weight were calculated. 
B) Organs weight  
 The animals were sacrificed on 60th day by cervical dislocation 
and then the different organs (kidney, liver and heart ) were removed dried and then 
weighed. 
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C) Biochemical lipid connstituents parameters 
 2ml of the blood was collected from retro orbital sinus puncture, and all the 
animals were sacrificed by cervical dislocation, and then the organs were removed and 
weighed. The collected blood was allowed to clot for 30 minutes, centrifuged and then 
used  for evaluating the lipid constituents and biochemical parameters.  
Biochemical lipid constituents/parameters — The main biochemical 
parameters recommended by the National Cholesterol Education Program (NCEP) 
guidelines (2002) for lipid screening as follows 
• Total Cholesterol (TC) 
• Low Density Lipoprotein Cholesterol (LDL)  
• Very Low Density Lipoprotein  
• Cholesterol (VLDL)  
• High Density Lipoprotein Cholesterol (HDL)   
• Triglycerides (TG) 
were evaluated from the serum. From the values, atherogenic index (TC:HDL) and 
LDL:HDL ratio  were calculated using the formula. 
serum glutamate oxaloacetate transferase(SGOT) and serum glutamate pyruvate 
transferase(SGPT) by standard method were  also evaluated from serum using standard 
methods. 
Cardiac risk indicators — The cardiac risk ratios recommended by NCEP guidelines 
(2002) were estimated by calculating the TC: HDL ratio (Atherogenic Index) and LDL: 
HDL ratio. The Friedewald formula was used to calculate serum low-density 
lipoprotein cholesterol(LDL-C) values and atherogenic index  as follows: 
                                                       LDL-C= TC__ (HDL-C+TG/5) 
 
                             Atherogenic index(AI)=(total cholesterol__HDL-C)/ HDL-C 
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7.4.4 HISTOPATHOLOGICAL EXAMINATION: 
A small portion of  aorta and liver was taken from each group and was 
immediately put in 10%  Formasal (formalin diluted to 10% with normal saline) and 
then it was processed. Sections were Stained with Ehrlich’s haematoxylin and Eosin 
to find out the Atherosclerotic lesions in aorta and to  find out cellular degeneration 
and necrosis in liver . 
Statistical Analysis    
Results were expressed as Mean ± SEM. The data was analyzed using one way 
analysis of variance (ANOVA) followed by Dennett’s test. P values <0.01 were 
considered as Significant. 
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8. RESULTS AND DISCUSSION 
 
7.1 PHARMACOGNOSTICAL STUDIES 
 
    7.1.1)  Table 9: Macroscopical characters of Caesalpinia sappan  Heartwood 
       
 
s.no 
 
Parameters Observation 
1 Colour Orange- red 
2 Taste Bitter 
3 Odour Slight 
4 Surface Grained 
5 Texture Fine and even 
6 Shape Straight 
 
 
7.1.2 MICROSCOPIC FEATURES 
 
Transverse section (TS) of the wood: 
Wood is porous (having the pores or vessels) The growth – rings are fairly 
distinct. The vessels are circular or ovate . They are mostly solitary or less frequently 
radial multiples of two to four vessels. The vessels have very thick walls which are 
lignified. Most of the vessels are open and some have gum deposits. The vessels are 
100-200 µm wide.   
 
Axial parenchyma :- 
  Parenchyma cells wich are vertically oriented are called axial parenchyma cells. 
The axial parenchyma is abundant . They occur as thin tangential layer along boundary 
of  the growth ring.Such parenchyma cells are called paratracheal parenchyma . The 
parenchyma cells are thick walled, lignified and have wide lumen.  
 
 
 
                                    RESULTS & DISCUSSION 
 
DEPARTMENT OF PHARMACOGNOSY, COP.MMC,CH-03 Page 59 
 
 
The xylem rays are seen in several closely running radial lines of parenchyma 
cells. The ray parenchyma cells are radially elongated, narrow lumened  and thick 
walled. They run in straight lines. Xylem fibres form the ground tissue of the wood. 
The fibres are angular in sectional view. They are compact; they have very thick, 
lignified walls. The cell lumen is reduced to a narrow hole. 
                                                                                                                                                                                                   
 
Fig14:  TS of wood showing vessel distributions. 
 
 
 
Fig 15:  TS of wood showing solitary vessels, growth ring. 
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Fig 16:  TS of wood showing radial multiples of vessels. 
 
G- gum deposition on the crosswall of the vessels; PPa- paratracheal parenchyma; 
BPa-boundary parenchyma; RM- radial multiples of vessels; Ve- vessels ; XF- xylem 
fibres; 
XP- xylem parenchyma; XR- xylem ray; GR-growth ring; SVe-solitary vessel. 
 
Tangential longitudinal section( TLS view ) 
 
In TLS view, the xylem rays spindle shaped; the vessels, axial parenchyma and 
xylem fibres are seen in vertical alignment.The rays are random in vertical orientation. 
So the rays are uniseriate , biseriate  or multiseriate . Thus the rays exhibit variations in 
seriation.The rays are either homocellular or heterocellular. The homocellular rays have 
uniform type of cells. The heterocellular rays have two type cells: the cells in the middle 
part of the rays isodiametric; the cell at the ray are vertically elongated. The 
isodiametric cells in the middle part of the rays are called procumbet cells; those at the 
ends of the rays are 300-600 µm in height and 50-100 µm thick. The ray cells are narrow 
and thick walled. 
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Fig 17:   TLS of wood showing axial parenchyma 
 
 
 
                                        Fig 18: TLS of wood showing gum, biseriate xylem rays. 
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Fig 19:  TLS of wood showing horizontal  ribbon shaped ray. 
 
GPI- gum plate; Ve- vessel; XFi- xylem fibres; XPa- xylem parenchyma; XR- xylem 
rays 
APa- axial parenchyma; BR- biseriate ray; Gu-gum; MR- multiseriate ray; Pc- 
procumbent cells; UC- upright cells; Ve-vessel; XFi- xylem fibres;  XPa- xylem 
parenchyma ; XR- xylem ray. 
 
Radial  longitudinal sections of the wood( RLS view)  
 
In RLS view, the xylem rays appear as wide and flat horizontal ribbon like 
bands. The xylem fibres, parenchyma and the vessels are at vertical rows at right angles 
to the rays. The procumbent cells of the ray are horizontally elongated, narrow and thick 
walled. The ray cells have dense simple pits. The upright cells are short, and squarish 
in shape.The axial parenchyma cells are long in vertical plane; they occur clusters of 2-
4 rows. The cells have minute circular pits. 
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Fig 20:  RLS of wood  showing horizontal ribbon shaped rays 
 
 
Fig 21:  RLS of wood showing ray cells enlarged. 
 
Pc- procumbent cells; Ve- vessel; XFi- xylem fibres;  XPa- xylem parenchyma; XR- 
xylem ray ; Uc – upright cells 
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Powder microscopic observations 
The powder preparations of the wood shows the following elements when observed 
under the microscope 
 
(i) Fibres:-Long, thin needle shaped fibres are abundant in the powder. They have 
thick lignified walls and much reduced lumen. The fibres are 600- 800 µm long 
and 20µm thick. 
 
                 
          
                       Fig 22:  xylem fibers                              Fig23: pitted vessel 
                
Pa- parenchyma;  XFi-xylem fibres. Pe- perforation; Pi- pits; Ve- vessel element. 
 
 
(ii) vessel elements:- 
Vessel elements are fairly common in the powder . vessel elements of 
the powder shows long thick vessel elements with prominent bordered pits, 
short wide vessel element and wide, short barrel shaped vessel element 
were identified.. These vessels elements are 250 µm long and 140µm wide 
.There are also wide, very short and drum shaped vessel elements which 
are 130µm long and 250 µm wide. The vessel elements have dense 
multiseriate elliptical bordered pits(Fig.22).  
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(iii) Parenchyma cells :- 
Rectangular , short parenchyma cells are occasionally  seen. The cells 
are thick walled with dense simple pits. The cells are 90 µm long and 15 µm 
wide ( Fig.23). 
 
7.1.3 PHYSICO CHEMICAL CONSTANTS  
Table 10:  Physicochemical constants on heartwood of Caesalpinia sappan Linn., 
            
 
 
    
 
 
S.NO PHYSIO-CHEMICAL CONSTANTS RESULTS (%w/w) 
I . 
                           ASH VALUE 
1. Total ash 1.22±0.02 
2. Water soluble ash 0.38±0.03 
3. Acid insoluble ash 0.13±0.01 
4. Sulphated ash 1.14±0.05 
II .                EXTRACTIVE VALUE 
1. Water soluble extractive 8.89±0.26 
2. Alcohol soluble extractive 4.80±0.3 
3. Ether soluble extractive 3.11±0.34 
III . Loss on drying 3.91 ±0.31 
IV . Foaming index <100 
V . Swelling index NIL 
                    Values are expressed as Mean ± SD, n=3 
                                    RESULTS & DISCUSSION 
 
DEPARTMENT OF PHARMACOGNOSY, COP.MMC,CH-03 Page 66 
 
   
1.4  INORGANIC ELEMENTS AND HEAVY METAL ANALYSIS 
Table 11: Qualitative estimation of inorganic elements of Caesalpinia sappan 
Linn., 
s.no 
INORGANIC 
ELEMENTS 
OBSERVATIONS 
1. Aluminium + 
2. Chloride + 
3. Copper + 
4. Calcium + 
5. Iron + 
6. Borate + 
7. Potassium + 
8. Silver + 
9. Phosphate - 
10. Nitrate - 
11. Sulphate - 
 
7.1.5   Table 12: Quantitative estimation of inorganic elements of  
Caesalpinia sappan  Linn., 
S.NO 
 
INORGANIC 
ELEMENT 
TOTAL AMOUNT 
(%W/W) 
1 Aluminium 0.028 
2 Chloride 0.052 
3 Copper 0.009 
4 Calcium 0.010 
5 Iron 0.028 
6 Borate 0.005 
7 Potassium 0.020 
8 Silver 0.007 
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Quantitative estimation of Heavy metals by ICP OES method 
  The quantification of the individual heavy metals was analyzed for the 
powdered mixture of Caesalpinia sappan Linn., by ICP-OES technique the following 
metals  like arsenic, lead, cadmium were detected and quantified, results are given in 
the following table 
 
 
                         Table 13: Quantitative estimation of Heavy metals 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The above observation showed that the material is within the limits as per WHO 
standard and it is safe to consume internally. 
 
 
 
 
 
S.No Element Results (ppm) Specification as per 
WHO Guidelines 
1. Mercury Not detected 
 
Not more than 0.5ppm 
 
2. Arsenic Not detected 
 
Not more than 5.0ppm 
 
3. Lead 0.002 
 
Not more than 10ppm 
 
4. Cadmium Not detected 
 
Not more than 0.3ppm 
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7.2 PHYTOCHEMICAL STUDIES 
      7.2.1    Table 14: Percentage yield of Hydroalcoholic extract  of  Caesalpinia 
sappan Linn., 
 
     
7.2.2 QUALITATIVE PHYTOCHEMICAL ANALYSIS 
                      
                  Table  15: Qualitative Phytochemical analysis 
                         Note:  +  indicates presence, - indicates absence . 
 
 
EXTRACT 
METHOD 
OF 
EXTRACTION 
PHYSICAL 
NATURE 
COLOUR 
YIELD 
(%W/W) 
 
Hydro-
alcoholic 
Cold maceration 
Crystalline 
powder 
Reddish Brown 12 
S.No Chemical constituents Powdered 
drug 
Hydroalcoholic 
extract 
1. Steroids + - 
2. Glycosides + + 
3. Saponins + + 
4. Flavonoids + + 
5. Tannins + + 
6. Phenolic compounds + + 
7. Proteins + + 
8. Alkaloid - - 
9. Carbohydrates + + 
10. Terpenoids + + 
11. Fixed oils and Fats + - 
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7.2.3 QUANTITATIVE ESTMATION OF PHYTOCONSTITUENTS 
The Caesalpinia sappan Linn., was found to contain various phytochemical 
constituents and hence it is desirable to quantify few of them in order to establish a 
standard to maintain its quality. Among them the estimation of total Saponins , 
Flavonoids and phenolic content in the hydroalcoholic extract were decided to be taken 
as parameters. Samples were drawn from three random samples of Caesalpinia sappan 
Linn., and the total  Saponins, Flavonoids and phenolic content present in them were 
estimated by HPLC method. 
 
Estimation of flavonoids by HPLC method 
          
 
              Fig 24: Graphical representation of Standard curves  for flavonoids 
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 Fig 25: Graphical representation of Hydroalcoholic extract curve for flavonoids 
Table 16:  Quantitative estimation of flavonoids present in hydroalcoholic 
extract. 
 
 
     
 
 
 
 
 
Estimation of phenolic content by HPLC method 
 
 
Fig26: Graphical representation of Standard curves for phenolic content 
 
Fig 27: Graphical representation of Hydroalcoholic extract curve for           
phenolic content 
Flavonoids Hydoalcoholic extract 
              per gm. 
Rutin             0.934mg 
Quercetin             0.184mg 
Gallangin              0.158mg 
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Table 17:  showing quantitative estimation of phenolic content present in 
hydroalcoholic extract. 
Phenols 
Sappan Extract 
Per gm. 
Gallic acid 0.519mg 
Tannic acid 0.083mg 
Ascorbic acid 0.987mg 
    
    ESTIMATION OF TOTAL SAPONIN CONTENT  
                        
           Table 18: QUANTITATIVE ESTIMATION OF SAPONIN 
 
Parameters Values ( µg/ml) 
Total saponins 8.24 ±0.15 
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7.2.4 FLORESCENCE ANALYSIS 
Table 19:Fluorescence characteristic of powdered samples and extract  
 
The green fluorescence observed  above indicates the presence of fluorescence 
compounds in Caesalpinia sappan . 
 
S.NO
 
TREATMENT
 
DAY LIGHT SHORT UV (254nm) 
  
LONG UV (366nm) 
1.
 
Powder
 
 
Orange red Yellow  Brown 
2. Powder + water 
  
Orange red Yellow Brown 
3. Powder + 
NaOH  
Red Reddish brown Violet 
4. Powder + Hcl 
  
Orange Yellowish brown Brown 
5. Powder + Acetic 
acid 
Orange Yellow Dark brown 
6. Powder + 
Alc.NaOH 
Red Brown Violet 
7. Powder + Picric 
acid 
Light orange Brown Green fluorescence 
8. Powder + 
Sulphuric acid 
Black Brown Black 
9. Powder + Nitric 
acid 
Orange brown Brown Cherry brown 
10. Powder + 
Iodine 
Brown Black Dark brown 
11. Powder + Fecl3 Brownish black Black Brown 
12 Hydroalcoholic 
extract 
Reddish brown Black  Brown 
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7.2.5 THIN LAYER CHROMATOGRAPHY OF EXTRACTS 
 
Table 20: Thin layer chromatography of hydroalcoholic extract at different 
solvent system. 
S.No 
Phyto-
constituents 
 
Solvent system 
 
Detecting 
agent 
No. of 
spots 
Rf  
value 
1. 
 
 
Saponin 
chloroform:  Glacial 
Acetic 
acid:methanol:Water 
(6.4:3.2:1.2:0.8) 
Iodine chamber        5 
 
0.28 
0.40 
0.54 
 0.71 
0.80 
 
2. 
 
 
Flavonoids 
 
Ethyl acetate: Formic 
acid: Glacial Acetic 
acid: 
Water(100:11:11:26) 
Iodine chamber 
 
       3 
        
 0.72 
0.83 
0.91 
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Fig 28: TLC of extract at      Fig 29:TLC of extract 
Saponin solvent system                                                      flavonoid solvent system. 
                       
HPTLC FINGER PRINT PROFILE 
 
HPTLC Finger print Data of hydroalcoholic  Extract of  caesalpinia sappan Linn.,  
 
High performance thin layer chromatography (HPTLC) finger printing was 
performed with the hydroalcoholic extract of caesalpinia sappan Linn.,. The 
chromatographic conditions were carried as detailed in material and method of this 
study. There were 13 peaks observed with different Rf Values and different heights. 
Percentage of areas was also obtained from the chromatogram. 
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SOLVENT SYSTEM 
Table 21: Solvent system for HPTLC 
 
 
Fig 30:  HPTLC Finger Print Data 
 
 
Fig 31: Graphical representation of  chromatographic finger printing analysis of 
the extract. 
                          
 
Extract Solvent System 
 
 
Hydroalcoholic extract 
 
Ethyl acetate : chloroform : methanol   
(5.3:1.5:0.5) 
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Table 22: HPTLC profile for  Hydroalcoholic  extract 
 
 
  
S.No Rf Height Area Lamda 
Max 
1 0.10 16.7 112.1 359 
2 0.12 7.8 99.2 205 
3 0.23 31.5 1590.9 256 
4 0.28 31.2 1449.0 255 
5 0.42 13.1 579.1 400 
6 0.44 13.9 584.3 400 
7 0.50 6.9 153.9 277 
8 0.51 6.5 130.9 277 
9 0.56 7.0 201.5 277 
10 0.60 15.2 262.6 277 
11 0.61 26.5 516.4 315 
12 0.72 3.9 44.5 277 
13 0.74 26.4 425.3 200 
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7.3PREPARATION OF FORMUULATION 
The raw materials were sampled, authenticated and analysed for their 
compliance to quality standards as established by WHO guidelines, pharmacopoeial 
and other standard reference books.   
7.3.1RAW MATERIAL STANDARDIZATION 
Table 23: Foreign organic matter determination 
 
 
Results are reported as mean ± standard deviation; (n=3): NMT- not more than. 
The raw material  standardization of  organoleptic evaluation, microscopical 
evaluation  and physico chemical evaluation were already given in the 
pharmacognostical and phytochemical studies of the plant. 
MICROBIAL LOAD ANALYSIS 
Tests carried out for the estimation of number of viable aerobic microorganisms 
present 
Table 24: microbial load analysis of the hydroalcoholic extract of  
Caesalpiinia sappan 
S.NO PARAMETERS CAESALPINIA SAPPAN 
EXTRACT 
1 Total aerobic count (NMT 1000cfu/g) 50cfu/g 
2 Yeast and mould count (NMT 100 cfu/g) 1 cfu/g 
3 E.Coli (To be absent) Absent 
4 Salmonella (To be absent) Absent 
 
5 Pseudomonas(To be absent) Absent 
6 Staphylococcus (To be absent) Absent 
Plant name Observation (w/w) Limit 
Caesalpinia sappan 0.44 NMT 2 
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7.3.2PREFORMULATION STUDIES 
3 trial batches of the herbal formulation were prepared and tested for 
preformulation parameters like bulk density, tap density, Carr’s index, Hausner’s  ratio 
and Angle of repose. The results observed is shown in table. 
                                       Table 25 Preformulation studies- trial batches 
                                                                    
                            
                                Table 26 a:  Evaluation of inprocess parameters 
 
 
     Parameters Trial-1 Trial-2 Trial-3 
 Bulk density  (g/cm) 0.42±0.01 0.38±0.05 0.35±0.04 
 Tap density    (g/cm) 0.45±0.03 0.47±0.01 0.50±0.04 
 
Compressibility        
index(%w/w) 
26.83±0.66 23.26±2.54 13.06±1.12 
   Hausner  ratio 1.35±0.15 1.22±0.02 
1.13±0.01 
 
 Angle of repose(o) 40.42±2.57 39.36±2.67 34.66±0.18 
 
                  All values are expressed as standard mean deviation ±, where n=3 
 
s.no 
Materials Trial1 
(g) 
Trial-2 
(g) 
Trial-3 
(g) 
\1 Caesalpinia sappan extract 20 20 20 
2 Talc 1.7 1.8 2.5 
3 Mcc 0.8 0.9 1 
4 Starch 2 2.5 2.6 
5 Magnesium stearate 0.8 1 1.5 
6 Colloidal sillicon dioxide 0.25 0.28 0.3 
7 Bronopol 0.15 0.15 0.15 
 
8 
Sodium methyl paraben 0.15 0.15 0.15 
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Table 26b: Evaluation of inprocess parameters. 
Parameters Trial-1     Trial-2 Trial-3 
Flow property Normal Fair  Perfect 
Filling Uniform Uniform Uniform 
Weight Not uniform Not Uniform Uniform 
Moisture 
content 
Satisfied Satisfied Perfect 
Disintegration 
time 
 
Within the 
limit 
Within the 
limit 
Perfect 
     
       As per the standards, the flow property of the blend to be filled in the capsules 
should be in good range and was confirmed by the above parameters. Trial batch- 3 
showed excellent flow characters and that batch was taken for capsule filling.  
The trial 3 flow properties were Excellent and all parameter  were within the 
Specified limits. So, third trial was chosen for further studies. 
 
7.3.5 STANDARDISATION OF FINISHED FORMULATION 
The final batch was tested for organoleptic characters , physical and physic 
chemical parameters. The results observed are shown in table 
                                          Table 27:Organoleptic characters 
Name of test Observations 
Description  Pale brown powder contained 
in purple cap/ transparent body 
“1” size capsule 
Colour Reddish brown powder  
Odour  Characteristic odour  
Taste Bitter  
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Table 28: Physical parameters 
 
        
 
 
 
 
                          Results (n-=3)  are reported as mean ± standard deviation. 
 1% aqueous solution of herbal formulation showed acidic pH.  
 The average weight of the capsules was calculated as per I.P and the obtained 
value was with in the limit (±10%). 
 Sample were taken randomly (3times) to specify quantity, the moisture content 
was calculated as per trail and error by KFR titration method. The result were 
given in the above table . 
 Disintegration time of the herbal capsule was performed as per I.P and the 
obtained value showed that the capsule will be disintegrated within the 
prescribed time for the absorption.  
 The uniformity of weight of the capsules was calculated as per the I.P and 
obtained value was within limit(±7.5).  
 The formulated  herbal capsule weight were the lower limit is noted as 248  mg 
and the upper limit is noted as 287mg.    
 
PRELIMINARY PHYTOCHEMICAL SCREENING  OF CAPSULES 
The herbal formulation was found to contain various phytochemical 
constituents and hence it is desirable to quantify few of them in order to establish a 
standard to maintain its quality. Among them the estimation of total phenolics, 
Flavanoids in the aqueous extract were decided to be taken as parameters. Samples were 
drawn from three random samples of herbal capsules and the phenolics, Flavonoids 
content present in them were estimated by HPLC method and it is given below. 
                        
  
Name of the test Observations 
Moisture content 3.6%±0.22 
Uniformity of weight 268mg±4.5mg 
Disintegration time 3.32(min)±0.34 
pH(1% aqueous solution ) 7.33±0.21 
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Table 29: preliminary screening of HECS herbal capsule 
 
The results were established a scientific data which can be used for the 
identification of the crude drugs. 
QUANTITATIVE ESTIMATION OF PHYTOCONSITUENTS OF HERBAL 
CAPSULES 
Estimation of flavonoids for HECS herbal capsule: 
 
Fig 32: Graphical representation of HECS herbal capsule for flavonoids 
 
S.No Chemical constituents 
Powdered 
drug 
HECS herbal capsule 
1. Steroids + - 
2. Glycosides + + 
3. Saponins + + 
4. Flavonoids + + 
5. Tannins + + 
6. Phenolic compounds + + 
7. Proteins + + 
8. Alkaloids - - 
9 Carbohydrates + + 
10. Terpenoids + + 
11. Fixed oils and Fats + - 
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Table 30: Quantitative estimation of  of flavonoids present in each herbal capsule 
 
 
 
 
 
 
 
Estimation of phenolic compounds for HECS herbal capsule : 
 
 
 
Fig 33: Graphical representation of Estimation of phenolic compounds for 
HECS herbal capsule 
 
 Table 31: quantitative estimation of phenolic compounds in each capsule 
 
Phenolic compounds HECS herbal capsule              
(250mg) 
Gallic acid  0.224mg 
Ascorbic acid 0.481mg 
Tannic acid  0.138mg 
 
    
From the results obtained it is determined that the average content of phenolics, 
Flavonoids were present in the herbal formulation. 
 
FLAVONOIDS 
HECS HERBAL 
CAPSULE ( 250 MG) 
Rutin                0.258mg 
Quercetin              0.091mg 
 
 
Gallangin               0.056mg 
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7.4 PHARMACOLOGICAL STUDIES 
 
7.4.1 ACUTE TOXICITY STUDIES 
Behavioural and physical observation of Caesalpinia sappan Linn., treated rats 
(2000mg/kg body weight)  
                                        Table 32: Observation of Acute toxicity study 
 
 
 
 
                                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note  :  NC-no change, A- absent, N- normal, P- present 
 
Acute toxicity studies were carried out as per the OECD Guidelines 423 and the HECS 
herbal capsules were found to be no morbidity and mortality upto 2000 mg/Kg body 
weight. Hence 1/10th and 1/20th of the dose (200 and 400mg/kg) were taken for the 
study  
OBSERVATION 30min           4 hrs 14 hrs 24 hrs 
Body weight  NC  NC  NC  NC  
Cage side observation  N N N N 
Motor activity  N N N N 
Convulsions  A A A A 
Piloerection  A A A A 
Righting reflex  P P P P 
Lacrimation  N N N N 
Salivation  N N N N 
Respiration  N N N N 
Skin color  N N N N 
Diarrhoea  A A A A 
Loss of corneal reflex  N N N N 
Loss of pinnal reflex  N N N N 
Grooming  A A A A 
Sedation  N N N N 
Excitation  N N N N 
Aggression  N N N N 
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7.4.2IN-VIVO HYPOLIPIDEMIC AND ANTI-OBESITY ACTIVITY 
    Changes in body weight from initial and final are tabulated in table 33 
                                           Table 33: changes in body weight 
   
Values are expressed as mean  ± SEM(n=6) 
              ‘a’ values are significantly different from normal control at P< 0.05 
              ‘b’ values are  significantly different from disease control at P <0.05 
 
Data are analysed by one way ANOVA followed by DUNNETT’S t-test. 
 
 
                       Fig: 34  Graphical representation of change in body weight 
0
100
200
300
Normal Contrl Standard Test 1 TEST 2
CHANGES IN BODY WEIGHT
1ST DAY 30TH DAY 60 TH DAY
           Groups        Changes in body weight % increase 
in body 
weight 
1st day 30th day 60th day       
Group 1 
(Normal control ) 
  150±7.07 153±6.32 154±5.49 2.5% 
Group 2 
(Disease  control) 
 154±8.01          183.3±12.11a 210±14.14a 36.36% 
Group 3 
(Standard control) 
160±14.14 185±10.48ab 166±8.01ab 4.1% 
Group  4 
(low dose 
200mg/kg) 
168±14.71 202±14.71ab 188±17.51ab 11.9% 
Group  5 
(high dose 
400mg/kg) 
166±11.14 200±12.64ab 174.16±8.16ab 4.9% 
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It is seen that there was a considerable increase in the body weight of animals which 
was treated with HFD induced obesity. This increase in body weight was much reduced 
in animals concomitantly treated with Atorvaststin and HECS herbal capsule in 2 doses 
of 200mg/kg and 400mg/kg. 
 
Effect of HECS herbal capsule on (different organs weight) HFD induced obesity 
in rats   
Various different organs weight were evaluated for all five groups and tabulated in 
Table - 
 
                               Table 34: Evaluation of organs weight 
 
 
Groups 
Different organ weights(g) 
 
heart 
 
Liver 
Kidney 
 
Right 
 
               Left 
Normal control 0.57±0.21 5.28±1.12 0.6±0.09 0.58±0.07 
Disease control 0.69±0.02a 6.13±2.45a 0.66±0.7a 0.56±0.5a 
Standard 
control 
0.56±0.12ab 4.32±3.20ab 0.57±0.45ab 0.52±0.72ab 
Test group 1 0.65±0.2ab 5.59±1.70ab 0.62±1.02ab 0.53±0.86ab 
Test group 2 0.59±0.31ab 5.02±1.45ab 0.61±1.04ab 0.50±0.04ab 
Values represents mean ± SEM (n=6); 
 ‘a’ values are significantly different from normal control at P< 0.05 
‘b’ values are  significantly different from disease control at P <0.05 
                        Data are analysed by one way ANOVA followed by DUNNETT’S t-test. 
It is seen that HECS herbal capsule remarkably decreases the organ weight of rats . 
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7.4.3Various lipid  profile parameters were evaluated for all five groups and tabulated 
in table - HECS herbal capsules were analysed for lipids parameters . 
Table 35: Effect of HECS herbal capsule on lipid profile 
 
GROU
PS 
TOTAL 
CHOLESTER
OL 
(mg/dL) 
TRIGLYCERID
ES (mg/dL) 
HDL  
(mg/dL) 
LDL  
(mg/dL) 
VLDL 
(mg/dL) 
Group 1 62.55 ± 5.54 73.32±5.57 23.22±2.31 24.67±1.63 14.66±2.7 
Group 2 195.2±10.56ab 115±5.47ab 17.71±6.10ab 154.42±7.52ab 23±2.01ab 
Group 3 65.43±2.62ab 72±11.12ab 24.30±3.10ab 25.66±3.32ab 14.4±2.10ab 
Group 4 78.56±6.46ab 85.24±5.55ab 19.62±4.56ab 42.42±3.66ab 7.84±2.68ab 
Group 5 69.72±5.62ab 76.5±5.69ab 24.14±3.13ab 30.33±3.51ab 15.3±2.11ab 
            Values are expressed as mean ± SEM 
Data are analysed by one way ANOVA followed by DUNNETT’S t-test. 
‘a’ values are significantly different from normal control at P< 0.05 
‘b’ values are  significantly different from disease control at P <0.05 
 
Fig 35 : Graphical representation of lipid profile 
It is seen that HFD treated groups, the lipid values were significantly higher 
than the control animals. Treatment with atorvastatin significantly reduced the lipid 
levels. Treatment with the HECS herbal capsule , at both doses also significantly 
reduced the lipid levels and increased the HDL level. At the high dose of 400mg/kg the 
protection offered was better.     
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Table 36: Effect of HECS herbal capsule on atherogenic index(AI) and LDL/HDL 
         
GROUPS AI LDL/HDL 
Group 1 1.69±0.23 1.06±0.70 
Group 2 10.02±1.62a 8.69±1.23a 
Group 3 1.69±1.01ab 1.05±1.07ab 
Group 4 3.00±1.36ab 2.16±0.80ab 
Group 5 1.88±1.03ab 1.25±1.12ab 
 
                                    Values are expressed as mean ± SEM 
 ‘a’ values are significantly different from normal control at p < 0.05  
‘b’ values are significantly different from diseased control at p < 0.05 
Data are analysed by one way ANOVA followed by DUNNETT’S t-test. 
 
The atherogenic index is an indicator of cardiovascular disease. The HFD treated group 
showed an increase level of atherogenic index compared to normal group. Herbal 
capsule treated groups showed decrease level of atherogenic index as compared to 
disease group. 
 
 
 
Fig 36: Graphical representation of atherogenic index 
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Table 37: Effect of HECS herbal capsule of Liver function test 
 
GROUPS SGPT 
(IU/L) 
SGOT 
(IU/L) 
Group 1 23.77±3.08 51.22±2.21 
Group 2 62.84±2.17a 112.70±1.71a 
Group 3 29.46±1.88ab 82.06±2.01ab 
Group 4 38.03±2.19ab 84.44±1.45ab 
Group 5 29.05±3.31ab 79.73±3.6ab 
 
   Values are expressed as mean ± SEM 
‘a’ values are significantly different from normal control at p < 0.05  
‘b’ values are significantly different from diseased control at p < 0.05 
Data are analysed by one way ANOVA followed by DUNNETT’S t-test. 
 
 
 
Fig 37: Graphical representation of liver function test 
   
Liver function parameters such as SGOT and SGPT also showed a significant 
increase in animals fed with cholesterol. These levels decreased significantly in the 
standard and extract treated groups. 
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7.4.4 Histopathological reports are given in figure 38 & 39 
                                        Fig 38:  HISTOPATHOLOGY OF LIVER 
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   FIG 39:HISTOPATHOLOGY OF RAT AORTA 
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Histopathology of liver: 
 
The high fat diet induced obesity  and abnormal lipid metabolism all collectively 
are associated with inflammation , congestion, and non-alcoholic fatty liver disease 
leading to hepatic failure causing a boost in SGPT, SGOT level in the serum. 
• Histopathological studies showed that the liver section was normal in normal 
control group. 
• The HFD treated group showed marked ballooning, cellular degeneration and 
inflammation. 
• These changes were absent in Atorvastatin treated standard group. 
• HECS herbal capsule (200mg/kg) treated test group 1 showed decrease in 
cellular degeneration and inflammation when compared to control group. 
• The test group 2 treated with HECS herbal capsule 400mg/kg showed maximum 
suppression of cellular degeneration and inflammation. 
 
Histopathology of aorta 
 
HFD intakes were shown to contribute to syndromes such as hyperlipidemia, glucose 
intolerance,hypertension and atherosclerosis. Atherosclerosis are main cause of   
cardiovascular and cerebro vascular diseases. 
 
• Histopathological studies showed that the aorta section was normal in normal 
control group. 
•  The HFD treated group showed marked atheromatous thickening (plaque) in 
the intima and atheromatous inflammatory changes.  
• These changes were absent in Atorvastatin treated group.  
• The HECS herbal capsule (200mg/kg) treated group showed decrease in 
atheromatous plaque size and inflammatory changes as compared to HFD 
treated group.  
• Wheareas 400 mg/kg of extract treated group showed maximum level of 
suppression of atheromatous plaque size and atheromatous inflammatory 
changes.  
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DISCUSSION 
 
PHARMACOGNOSTICAL STUDIES 
 
          Pharmacognostical studies play a key factor in establishing the authenticity of the 
plant material. The botanical identity of the heartwood was established by examining 
its anatomical features. 
 
          The macroscopic and microscopic features of the heartwood of Caesalpinia 
sappan were studied. Some of the characteristic features of the heartwood are ; 
 
• The anatomical examination of Caesalpinia sappan Linn., heartwood  exhibited 
important  microscopical features like multiseriate  medullary rays in TLS view 
and ribbon shaped medullary rays in RLS view, pitted vessels, numerous xylem 
fibers, large vesicles and parenchymatous cells. 
 
• Physiochemical parameters are mainly used in judging the purity and quality of 
the powdered drug. Ash values of a drug give an idea of the earthy matter or 
inorganic elements and other impurities present along with the drug. 
 
• Ash value is an important parameters to find the low grade product and 
exhausted drugs. A high ash value is an indicator of substitution, contamination 
and adulteration. The total ash value was found to be 1.22±0.02 %w/w. The  
acid insoluble, water soluble and sulphated ash was found to be 
0.13±0.01%,0.38±0.03 % and 1.14±0.05%  respectively. 
 
• Extractive value is helpful for the prediction of nature of constituents. The water 
soluble, alcohol soluble, ether soluble (volatile oil) was found to be 
8.89±0.26%, 4.88±0.3%, 3.11±0.34%.  
 
• Loss on drying determines the amount of volatile matter present and it was 
found to be 3.91±0.31    %. There is no swelling index which indicates that the 
powder was devoid of sticky mucilage and the foaming index was found to be 
less than 100. 
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• Presence of inorganic elements and heavy metals were analysed qualitatively 
and quantitatively. The inorganic metal analysis showed the absence of toxic 
metals. The quantification of heavy metals shows the presence of elements 
within the limit. 
 
The detailed pharmacognostical studies on the heartwood of Caesalpinia sappan 
Linn., provides information on the standardization parameters and physiochemical 
parameters which is essential  for the identification of raw material and also used to 
differentiate the plant from its adulterants and substitutes. 
 
From the above results a complete profile of pharmacognostical parameters was 
evolved.  
 
PHYTOCHEMICAL STUDIES 
 
        Since herbal medicines are prepared from materials of plant origin they are prone 
to contamination, deterioration and variation in composition. Hence, before proceeding 
to clinical studies, scientists need a tool to authenticate plants and also to detect their 
potency. 
 
      A lot of analytical techniques have been developed for quality control of drugs from 
plant origin. Therefore it is very important to undertake phytochemical investigations 
along with biological screening to understand therapeutic efficacy of medicinal plants 
and also to develop quality parameters. 
 
• In this analysis different polarity of Phytoconstituents were sorted out from the 
coarsely powdered heartwood of Caesalpinia sappan Linn., by using solvents 
of ethanol and water (1:1) of hydroalcoholic extract  by using cold maceration 
extraction. 
 
• Qualitative preliminary phytochemical analysis was performed initially with 
different respective chemical detecting agent to detect the Phytoconstituents 
nature and their presence in each extract and powder. 
                                    RESULTS & DISCUSSION 
 
DEPARTMENT OF PHARMACOGNOSY, COP.MMC,CH-03 Page 94 
 
 
• Quantitative estimation of saponins, phenolic contents, flavanoids,  and 
fluorescence analysis of extracts with different chemical reagents were  carried 
out. flavonoids  and phenolic content by HPLC method and  saponin content by 
gravimetric method. Rutin, quercetin and gallangin were found to be present in  
quantitative amount  in the flavonoids estimation and in the phenolic content 
estimation gallic acid, tannic acid and ascorbic acid was found to be present in 
the hydroalcoholic extract of the plant. 
 
• Qualitative chromatographic analysis of hydroalcoholic extract were done by 
using Thin Layer Chromatography to separate and identify the single or mixture 
of constituents present in  extract. The following solvents system was used to 
separate the phytoconstituents by using Ethyl acetate: Formic acid: Glacial 
acetic acid: Water (100:11:11:26). 
 
• High performance thin layer chromatography (HPTLC) finger printing was 
performed with the hydroalcoholiic extract . There were 13 peaks observed with 
different Rf values and different heights. Percentage of areas were also obtained 
from the chromatogram. 
 
The phytochemical  studies showed the presence of flavonoids, phenolic content 
and saponins .This may be responsible for the potent hypolipidemic and anti-
obesity activity. 
 
FORMULATION STUDIES 
 
• The herbal raw materials were analyzed for their identity, quality and purity. 
The raw materials were standardized according to WHO Guidelines and 
Ayurvedic Pharmacopeia of India. Materials which complied with  the 
specification were taken for further studies. The optimized herbal formulation 
was evaluated for various physiochemical and phytochemical parameters.  
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• The formulation was optimized for it quality measures and its  batch consistency 
by making three different trials (Trial I, II, III).The trails were subjected to pre 
formulation parameters to confirm the uniformity and quality. 
 
• The result concludes that the trial III was excellent in all parameters and the 
values were found within the standard limits. Quantitative estimation of 
phytoconstituents were done for  flavonoid, saponin and phenolic compounds . 
 
• Accelerated stability studies were carried out as per ICH Guidelines for a period 
of three month. The resultant stability data has shown that the formulation is 
stable under accelerated stability conditions. 
 
• Acute toxicity studies were carried out and the herbal capsules were found to 
be very safe upto 2000 mg/Kg body weight by Acute toxicity study as per the 
OECD Guidelines 423. 
    
 
PHARMACOLOGICAL STUDIES 
Pharmacological  studies were carried out  for assessing the hypolipidemic and Anti- 
obesity of the plant Caesalpinia sappan Linn.,  
 
• Acute toxicity studies of the HECS herbal capsule were carried out for a period 
of 14 days. It did not produce any behavioural changes or mortality up to the 
dose of 2000 mg/kg of body weight of rat.  
• So the LD50 value in the range of 2000 to 5000 mg/kg of body weight .So the in 
vivo studies were carried out a dose of 200 mg/ kg and 400 mg /kg. 
 
• The high fat induced obesity in rats model and cholesterol 400mg/kg was used 
to induce hyperlipidemia and obesity in rats.  
 
• The in-vivo studies showed that the hydroalcoholic extract of Caesalpinia 
sappan (HECS) herbal capsule, especially at a higher dose, improved the lipid 
profiles of the animals. 
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• The total cholesterol and LDL cholestertol levels were decreased whereas the 
HDL cholesterol level showed an increase.  
 
• The atherogenic index is an indicator of cardiovascular disease. A high 
atherogenic index indicates a higher risk of cardiovascular disease. The 
atherogenic index decreased in standard group and herbal capsule treated 
groups. 
 
• The animals which were treated with high dose (400mg/kg) of the capsule 
showed a greater improvement in atherogenic index. 
 
• Human studies have revealed that increased fat intake is associated with body 
weight gain, which can lead to obesity and other related metabolic diseases. This 
study proves that rats exposed to high fat diet for 60 days cause  significant 
increase of animals body weight, thus verifying the rats obese. The animals 
which were treated with high dose of 400mg/kg of the HECS herbal capsule 
showed a decrease in animals body weight and internal organs weight.  
 
All the parameters reveal the potent  hypolipidemic and anti- obesity activity of 
the HECS herbal capsule of Caesalpinia sappan Linn.,. 
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9. SUMMARY 
Herbal medicines are found to be effective in treatment of various aliments but the major 
lacuna is lack of proper scientific validation .Hence the present study is aimed at investigating 
the selected plant Caesalpinia sappan  Linn., for the hyperlipidemic and obesity problem. 
The plant Caesalpinia sappan Linn., belong the family Caesalpiniaceae, is claimed to 
be useful for hypercholesteremia, but the claim has not been  scientifically validated. 
Authentication of the plant material plays a key role in pharmacognostical studies. The 
plant  Caesalpinia sappan Linn., was collected from kulasekaram, kanyakumari district, and 
authenticated by Dr.V. Chelladurai, Research officer in siddha and ayurvedha.  
The parameters studied were Macroscopy, microscopy, powder microscopy and 
physicochemical constants to establish data for proper authentication and detection of 
adulterants. 
The qualitative and quantitative analysis were carried out  to identify  inorganic 
elements present in the plant.  
The qualitative and quantitative analysis of toxic heavy metals like Cadmium, Arsenic, 
Lead and Mercury were within the WHO limits and ensure the safety of the drug . 
In phytochemical analysis, extraction is the first step involved. The coarse powder was 
extracted by ethanol and water (1:1)by cold maceration method . 
The preliminary phytochemical screening of various  extract of the plant have revealed 
the presence of constituents like flavonoids , saponins, tannins , glycosides, carbohydrates, 
triterpenes ,and terpenoids .   
HPLC analysis of hydroalcoholic extract was carried out to estimate the quantitative 
amount of flavonoids and phenolic content present in the extract. 
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TLC and HPTLC analysis of hydroalcoholic extract was carried out to identify 
phytoconstituents present. 
The preparation of herbal capsule on heartwood of Caesalpinia sappan(HECS) for 
clinical trial in rats and to investigate the hypolipidemic and anti-obesity potency of the 
formulation. 
The herbal raw materials were analyzed for their identity, quality and purity. The raw 
materials were standardized according to WHO Guidelines and Ayurvedic Pharmacopeia of 
India. Materials which complied with the specification were taken for further studies. The 
optimized herbal formlations was evaluated for various physiochemical and phytochemical 
parameters.  
The physiochemical constants like Loss on drying, pH, Ash values and Extractive value 
were determined, which will help in preventing variation in quality of the drugs. 
The heavy metal analysis and the microbial load analysis were carried out as per the 
WHO Guidelines to check its limit. These were found to be within the limits. 
Accelerated stability studies were carried out as per ICH Guidelines for a period of three 
month. The resultant stability data has shown that the formulation is stable under accelerated 
stability conditions. 
The quantitative analysis of phytoconstituents especially of flavonoids and phenolic 
content in extract and formulated herbal capsule was estimated by HPLC method showed the 
presence of rutin, quercetin, gallic acid, ascorbic acid and tannic acid.  
  Hypolipidemic and anti-obesity activity was assessed by method of high fat induced 
obesity in rats.The parameters studied were increase in body weight changes and organs weight, 
lipid profile parameters, liver function test and histopathological studies. 
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   Hydroalcoholic extract of Caesalpinia sappan (HECS) herbal capsule was evaluated 
for acute toxicity studies in albino wistar rats and showed no toxicity upto 2000mg/kg. 
  In-vivo evaluation of high fat diet (HFD) induced obesity in rats was carried out for 
HECS herbal capsule .The studies showed HECS herbal capsule(250mg/kg and 500mg/kg) 
significantly reduced the elevated levels of body weight, total cholesterol, triglycerides, LDL-
cholesterol, VLDL-cholesterol, SGPT and SGOT  and elevate the decrease level of HDL-
cholesterol. 
 Histopathological studies of aorta and liver of all treated group shows that they are 
normal and architecture is preserved. 
 These results suggest that, HECS capsule possess good hypolipidemic and anti-obesity 
activity, which may be due to its flavonoid, saponin and phenolic content.             
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CONCLUSION 
Sappan wood with high therapheutic effect and vast folklore uses is a rich natural 
resource of lead compounds for drug development.  Based on literature review, Caesalpinia 
sappan heartwood has high potential for therapeutic and colouring use. 
 Brazelien has potential pharmacological activity such as anti-tumour, anti- 
inflammatory, anti-diabetic ,immunostimulant properties and also anti thirst, blood purifying 
action and  healing properties in Aurvedha and Unani  beneficial to develop into  a drug , 
neutraceuticals and cosmetics. 
Future studies can be directed towards the Isolation, Characterization of individual 
compounds responsible for the hypolipidemic and Anti-obesity activity and mechanism of 
action responsible for this activity, so as to explore this plant for therapeutic purposes. 
Further Scope: The developed herbal formulation may be taken up for clinical trials in 
the treatment of  hyperlipidemic and obesity problems.  
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ABSTRACT:
The plant Caesalpinia sappan is a  small leguminous tree upto 10m in height belonging to the Caesalpiniaceae
family,with an orange-red hard Heartwood with spiny trunk ,which besides being useful in turnery gives a red
dye. It is commonly known as Brazil or Sappan wood, native to tropical Asia, also grown as a hedge plant. The
plant is being used worldwide for a large number of traditional medicinal purposes including  anti-tumour,  anti-
inflammatory, immunosuppressive, anti-diabetic, anti-allergic, cardioactive,  neurotoxicity, anti-bacterial, anti-
acne , anemia, tuberculosis  and some other activities. The main active constituents is Brazilin, and together
triterpenoids, flavanoids, lipids, steroids, aminoacids etc are found. Leaves yield volatile oil, 0.16 to 0.25%; pods
contain 40% tannin; seeds yield 32.1% and 34.4% mucilage and straw –yellow , edible oil(7.5%) having a
characteristic smell; roots contains caesalpin-type diterpenoids along with sitosterol.  In folklore medicine it is
used as a herbal drinking water for its blood purifying, anti- thirst , anti-tumour and to improve complexion in
Kerela. It has the potential to hit the market as a safe natural colouring agent with good medicinal value for
pharmaceuticals, food products and beverages. The plant is one of the ingredients of an indigenous drug ‘Lukol’
which is administered orally for the treatment of non-specific leucorrhoea. The present article  summarizes
review on the plant, its phytochemistry and its pharmacological activity which have been reported.
KEYWORDS: Caesalpinia sappan, phytochemicals, Anti-tumour,  Immunosuppressive, Cardioactive.
INTRODUCTION:
Caesalpinia sappan with highly interesting biological
effects and vast folklore uses is worth studying more that
might provide a rich natural resource of  lead compounds
for drug development. This plant enjoys the open
altitude of 1000m above sea level and grows well in
mountaineous areas that are not too cold (Fig 1). It is
cultivated wild in west Bengal, Madhya Pradesh, orissa,
These plant belongs to family Caesalpiniaceae, shaped
small tree, 5-10m high; 15-25cm diam, spiny trunk and
branches rufous-pubescent, stem round brownish green
colour (Fig 2).
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Propagation by seed or stem cuttings. Leaves 20-38cm
long, pinnae 8-12 pairs, 10-15cm. Long , subsessile, with
small prickles at  the base. Leaflets 10-18pairs,
subsessile, close, oblong, rounded at the apex, attached
at the lower cornor, very in equilateral, glaborous above,
more or less puberulous beneath (Fig 3)
Flowers in panicles, which are terminal and in the axils
of the upper leaves, 30-40cm long; pedicles 1.3-1.5cm
long, bracts lanceolate, 8mm long, caducous. Calyx
11mm, long , leathery, glaborous, corolla 2cm across;
petals orbicular subequal, yellow, the upper with a red
spot at the base, stamens delicate, waxy-white, filaments
densely woolly at the base (Fig 3).Pods 7-10 by 3.8-
5cm,woody, obliquely oblong, sub compressed,
polished, indehiscent with a hard returned short beak at
the upper angle of the obtuse apex (Fig 4) Seeds 3-4.
wood has outer sapwood which is white pale buff colour
and inner orange red heartwood(1-2) (Fig 5). The wood
was formely used in calico printing of cotton, wool and
silk. It is now however now replaced by synthetic dyes3.
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Fig 1 Caesalpinia sappan Fig 2 Spiny trunk
Fig 3  Leaves and Flowers Fig 4  Pods with Seeds Fig 5 Heartwood
TAXONOMIC CLASSIFICATION4
Kingdom :  Plantae
Sub kingdom : Viridiplantae
Infra kingdom :Streptophyta
Super division : Embryophyta
Division :Tracheophyta
Sub division : Spermatophytina
Class :Magnoliopsida
Super order :Rosanae
Order :Fabales
Family :Caesalpiniaceae/Fabaceae
Genus :Caesalpinia Linn.
Species :Caesalpinia sappan Linn– Sappan
wood
PLANT CHEMICALS:
A great deal of chemical investigation has been carried
out in this plant and presence of compounds, viz:
triterpenoids, flavanoids, steroids, oxygen heterocycles,
and aminoacids has been reported in the heartwood and
seeds of this plant3,5.  Brazilin, the main constituent of
plant is oxidised to produce Brazilein by air and light3.
Two new aromatic compounds structurally related to
brazilin were isolated and identified from the heartwood
of sappanwood. They possessed anti-hypercholesteremic
activity6. The wood is reported to containing β-amyrin
and glucose, and the free aminoacids: alanine, aspartic
acid, glycine, proline, valine, leucine, threonine; free
sugars: lactose, galactose, sorbose, 4-methyl galactose,
3,4-dimethyl galactose;2-deoxyribose and glucose are
also present7. The petroleum ether extract of the
heartwood gave 1.15% of a fixed oil(sap val,204.2; and
iod val, 28.8) having the following fatty acid
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composition: palmitic 27.6; stearic , 44.2; linoleic, 25.9;
and oleic, 2.23%.The heartwood contains flavanoids and
homoisoflavanoids. It also contain ns sappanol,
episappanol, 3’-o-methylepisappanol, 3’-deoxysappanol,
3’-o-methyisappanol, 3’-o-methylbrazilin, 4-
methylsappanol, quercetin, rhamnetin and ombuin is also
reported7,8. Two new phenolic compounds, epicaesalpin
j and 7,10,11-trihydroxydracaenone, were isolated from
the heartwood of sappan9. Tannin is found in the leaves
19%, bark 44%, and pods 40%. Leaves yield volatile oil,
0.16 to 0.25%; d-α-phellandrene, terpene and methyl
alcohol10
TRADITIONAL USES:
There are innumerable traditional medicinal uses of this
plant. The plant is one of the ingredients of an
indegenous drug ‘Lukol’ which is administered orally
for the treatment of non-specific leucorrhoea (post-
I.U.D), and gave encouraging results for bleeding
following I.U.D-insertion11.The decoction of the wood is
considered as a powerful emmenagogue, astringent,
sedative, stomachic, postpartum tonic, vulnery,
tuberculosis, anemia, diuretic, used by women as tonic
after confinement and also for vomiting of blood 12 in
Ayurvedha and Unani. The wood is suitable for making
cabinet-making, walking-sticks, and small ornamental
turnery articles like dagger sheaths and hilts. Brazilin
dye is reported to have anti-inflammatory activity13. The
plant pigments find use in manufacture of facials which
are resistant to light, heat and water, and non-irritating.
The dyeing properties of wood is used in colouring food
products, icecreams, bakery, confectionaries, beverages
etc. The wood is the component of  ‘vicco vajaradanti’TM
a famous tooth powder and paste of  India. Its folkloric
uses includes- in kerela , decoction of heartwood used
for blood purifying, anti-thirst, anti-diabetic, and to
improve complexion. In Ayurveda, useful  in vitiated
conditions of  Pitta, burning sensations, wounds, ulcers,
leprosy, skin diseases, diarrhoea, dysentery, and
diabetes. In Thailand , used for arthritis, cancer, and
inflammatory complaints. In Indo-china, seeds used as
stomachic.2
PHARMACOLOGICAL ACTIVITY
ANTI-INFLAMMATORY ACTIVITY:
The methanolic extract of the heartwood showed anti
inflammatory activity. The active constituent  Haematin
isolated from the heartwood used in oriental medicine
act both as an analgesic and anti inflammatory agent. In
the test conducted for inhibition of hyaluronidase
activity, among 130 herbal medicines , sappan Lignum
one of the six acive plants, its methanol extract at
5mg/ml concenteration showed more than 50%
inhibition of  hyaluronidase activity. Study evaluated the
effects of an ethanolic extract on human chondrocytes
and macrophages. Results showed an anti-inflammatory
effect in an invitro cell model of joint inflammation14.
CYTOTOXICITY AND ANTI-TUMOUR
ACTIVITY:
The anti cancer activity of brazilein, a compound
isolated from Caesalpinia sappan was investigated.
MTT assay showed that the IC50 value of brazilein
against human breast cancer MCF-7 cells was 7.23±0.24
umol/L. Western blot, RT-PCR assay, and RNA
interference assay illustrated that  brazilein induced
growth inhibition of breast cancer cells and down
regulation of GSK-3β/β-catenin pathway was involved
in its mechanism.15 The chloroform extract induces cell
death in head and neck cancer cells lines. It resulted in
increases in the HNSCC4 and HNSCC31 cells, which is
linked to increased cellular levels of p21 WAF1/CIP1.
Sappan wood act as a anti tumour agent in oriental
medicine16. Methanol and water extracts exhibited
marked cytotoxic activity against human cancer cells
lines such as  HeLa, MDA MB, A 549, and HCT-15 in
the MTT assay. The water extract obtained from the
heartwood of caesalpinia sappan has shown promising
cytotoxic and apoptotic potential.   The in vivo study in
albino mice using Ehrlich carcinoma model resulted in
an increase in the life span17.
HEPATOPROTECTIVE ACTIVITY:
Anti hepatotoxic effect of methanolic extract was
observed in freshly isolated rat hepatocytes at
concenteations 1000-800 micro g/ml and was  found to
be similar to that of standard drug silymarin. Both
extracts was abel to restore the biochemical levels to
normal which were altered due to ccl4 intoxification in
freshly isolated rat hepatocytes and also in animals.18
The methanol and aqueous extracts of heartwood of
Caesalpinia Sappan for its hepatoprotective activity
against ccl4 induced toxicity in freshly isolated rat
hepatocytes and animals19.
IMMUNOSUPPRESSIVE ACTIVITY:
Brazilein an important immunosuppressive component
of  sappan showed inhibition of  T cells proliferation and
suppress mice humoral immune response. Ethanol
extract of sappan heartwood suppress the immune
competence of  lymphocytes , water extract affect T cells
function and its ester extract can affect immune
competence and NK cells. Ehanol extract has the
strongest immunosuppressive function20.
ANTI OXIDANT ACTIVITY:
Brazelien showed highest DPPH radical scavenging
activity and ferric reduction activity as compared to
standard vitamin E and other compound isolate from
sappan lignum including brazilein, sappanchalcone,
protosappanin B  and C. It also showed dose dependant
inhibition of peroxide formation in linoleic acid
emulsion during incubation at 500 c for 250h21.
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ANTI ALLERGIC ACTIVITY:
The dichloromethane extract of the roots and heartwood
of Sappan lignum exhibit potent inhibitory activity
against β- hexosaminidase release as marker of
degranulation in rat basophilic leukemic cells, with
inhibition of 98.7% and 87.5% at concenteration of
100ug/ml, respectively. Sappanchalcone possessed the
most potent effect against allergic reaction in rat
basophilic leukemic ( RBL 2H3)  cells with an inhibitory
concenteration (IC50) value of 7.6um22.
CARDIOACTIVE EFFECTS OF BRAZILEIN:
Ethanol extract of  Sappan lignum obtain brazilein. In
isolated cardiac tissues, brazilein exhibited a  +ve
inotropic action in a concenteration dependant manner
with little effect on heart rate and coronary perfusion.
Albino guinea pig erythrocytes enriched with Na+ K+,
ATPase  isoforms were utilized to compare the inhibition
promoted by brazilein with that of classical inhibitors
such as cardiac glycosides deslanoside. The extent of
maximum inhibition rate was about 50%. Brazelien
produced its positive inotropic effect through inhibiting
Na+ K+-ATPase .23
HYPOGLYCEMIC ACTIVITY:
Brazilin, the principle component of sappan lignum has
been found to exhibit hypoglycaemic properties and to
increase glucose metabolism in diabetics rats.  It
improved glucose metabolism in cultured rat
hepatocytes, also increased basal glucose transport in 3T
3L1 fibroblasts and adipocytes , but insulin stimulated
glucose transport was not influenced.24
ANTI ACNE ACTIVITY:
Brazilin isolated from Sappan lignum possessed
antibacterial activity against propionibacterium acnes
with MIC and MBC  values of 15.6 and 31.2ug/ml,
respectively. Brazilin rich extract considered as a
potential coloring agent with anti bacterial and acne
activity which is used for pharmaceutical, cosmetic, and
neutraceutical applications.25
MELANOGENESIS INHIBITORY ACTIVITY:
Homoisoflavanone, sappanone A, was isolated
from Caesalpinia sappan and proven to dose-
dependently inhibit both melanogenesis and cellular
tyrosinase activity via repressing tyrosinase gene
expression in mouse B16 melanoma cells. sappanone A
is the first homoisoflavanone to be discovered with
melanogenesis inhibitory activity. Results gave a new
impetus to the future search for other homoisoflavanone
melanogenesis inhibitors26.
OTHER ACTIVITIES:
The Caesalpinia  sappan possessed various reported
activities such  as  anti osteoporotic activity27,
suppression of melanin synthesis28, anti helmintic29, anti
bacterial30,  anti influenza virus31 , vasorelaxant32 were
also reported in this plant. Toxicity evaluation of Sappan
wood extract  showed it did not produce any acute or sub
acute toxicity upto 5000 mg/kg in rats33.
CONCLUSION:
Sappan wood with high therapheutic effect and vast
folklore uses is worth studying more that might provide
a rich natural resource of lead compounds for drug
development. Medicinally  the wood is recommended as
a substitute for logwood. It has vast uses in ayurveda
and yunani.  Based on literature review, Caesalpinia
sappan heartwood has high potential for  therapeutic and
colouring use. Dyeing properties  which has a use in
colouring foods such as hard cheese, butter, dairy
products, fish products, beverages, bakery, ice creams
etc.  Brazelien has potential pharmacological activity
such as anti-tumour, anti inflammatory, anti-diabetic,
immunostimulant properties and also anti thirst, blood
purifying action and  healing properties in Aurvedha and
Unani  beneficial to develop into  a drug , neutraceuticals
and cosmetics.
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ABSTRACT 
The present work was undertaken to establish the pharmacognostic and phytochemical standards 
of Heartwood of  Caesalpinia sappan L. It is a highly apparent plant in ayurvedic system of 
medicine for the treatment of various ailments. The plant is traditionally used for the treatment of  
dysentery, cancer, worm infestation, anemia, to improve complexion and ulcer . In the present 
study, pharmacognostical studies of the heartwood were carried out. The parameters studied are 
macroscopy, microscopy of heartwood, powder microscopy,  heavy metals analysis and HPLC. 
HPLC analysis of hydroalcoholic extract of heartwood showed presence of rutin, quercetin, gallic 
acid, ellagic acid and ascorbic acid in variable amount. All the parameters were studied according 
to the WHO & Pharmacopoeial guidelines. This parameters will help for correct identification of 
this plant for the future references. 
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INTRODUCTION 
The plant Caesalpinia sappan is a small leguminous tree  belonging to the Caesalpiniaceae 
family,with an orange-red hard Heartwood ,which besides being useful in turnery gives a red dye. 
It is commonly known as Brazil or Sappan wood, native to tropical Asia, also grown as a hedge 
plant. The plant is being used worldwide for a large number of traditional medicinal purposes 
including anti-tumour, anti-inflammatory, immunosuppressive, anti-diabetic, anti-allergic, 
cardioactive,  neurotoxicity, anti-acne , anemia, tuberculosis  and some other activities. The main 
active constituents is Brazilin, and together triterpenoids, flavanoids, lipids, steroids, aminoacids 
etc are found(1,2). In folklore medicine it is used as a herbal drinking water for its blood purifying, 
anti- thirst , anti-tumour and to improve complexion in Kerela. The plant is one of the ingredients 
of an indigenous drug ‘Lukol’ which is administered orally for the treatment of non-specific 
leucorrhoea3. The wood was formely used in calico printing of cotton, wool and silk. It is now 
however now replaced by synthetic dyes4. 
 
MATERIALS AND METHODS 
COLLECTION AND AUTHENTICATION OF THE PLANT MATERIAL: 
The Heartwood of  Caesalpinia sappan Linn., was collected from Kulesekaram in Kanyakumari 
district, Tamilnadu in June-2015. The plant material was authenticated by Dr.V.Chelladurai, 
Research officer- Botany, Central Council for Research in Ayurveda and Siddha, Tirunelveli. The 
heartwood were shade dried, Coarsely powdered and used for further studies. The macroscopical 
Characters of Caesalpinia sappan heart wood such as odour, taste, shape, texture and surface were 
observed . 
 
PHARMACOGNOSTICAL STUDIES: 
a) Morphology:Morphological studies such as shape, size, surface, colour, taste, texture of  
heartwood(Fig-1) were carried out and showed in table-1  
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                                                         Fig-1 Heartwood  
 
b) Microscopy 
The required sample of heartwood were cut and removed from the plant and fixed in 
FAA(Formalin-5 ml + Acetic acid-5 ml + 70% Ethyl alcohol 90 ml). The shade dried heartwood 
of  Caesalpinia sappan were powdered well and then the powder was passed through sieve no:60 
and used for powder analysis.An exhaustive pharmacognostical study was carried out using 
standard Methodology (5-16). 
 
EXTRACTION 
About 200 gm of coarsely pulverized heartwood was taken in a closed bottle and it was defatted 
with petroleum ether. The deffating was continued for 9-10 days with occasional shaking. The 
petroleum ether extract was filtered. The marc left after petroleum ether deffating was taken out 
and dried under shade to get a dry mass, then extracted with ethanol and water(50:50) by using 
cold maceration extraction. The extraction was continued for 9-10 days with occasional shaking. 
The hydroalcoholic extract was filtered, concentrated under reduced pressure to a semisolid mass 
and was made free from solvent. The final obtained extract was weighed; percentage yield was 
calculated and stored in a cool place. 
 
PHYTOCHEMICAL STUDIES: 
 Phytochemicals are non-nutritive plant chemicals that contain protective and disease preventing 
compounds. They are involved in many process including ones that help to prevent cell damage, 
prevent cancer cell replication and decrease cholesterol levels. Preliminary Qualitative 
phytochemical evaluations were carried out on hydroalcoholic extracts and dried powder to 
identify the presence of various phytochemical constituents like flavonoids, phenolic compounds, 
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glycosides, saponins, tannins were detected17. Particularly flavonoids and phenolic compounds 
were detected by HPLC method. 
  
QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
 
Estimation of flavonoids18 : 
Method : HPLC 
Extraction solvent- Mixture of alcohol, water and HCl (50:20:8) 
Mobile phase- A mixture of methanol, water and phosphoric acid (100:100:1) 
Standard solutions- Accurately   weighed quantities of USP quercetin RS, Rutin, Gallic acid, 
Thymoquinone, Gallangin  to separate volumetric flasks, which is dissolved  in methanol, and 
diluted quantitatively, and stepwise if necessary, with methanol to obtain standard solution 1 
mg/ml, respectively. 
Test solution – About 10g of hydroalcoholic extract were weighed to a 250 ml flask fitted with a 
reflux condenser. 78ml of extraction solvent added and refluxed on a hot water bath for 135 
minutes. Then it was allowed to cooled at room temperature. Decanted to a 100 ml volumetric 
flask. Then 20ml of methanol added to 250 ml flask, sonicated for 30 minutes, filtered and the 
filterate was collected in 100 ml volumetric flask, the residue was washed on the filter with 
methanol. Then the washing was collected in the same 100 ml volumetric flask, diluted to volume 
and mixed. 
Chromatographic system – The liquid chromatograph was equipped with a 270 nm detector and a 
4.6mm x 25 cm column that contains packing L1. The flow rate was about 1.5ml per minute. 
Chromatograph standard solution 1 and the peak reponses was recorded.(Fig 12 & 13) 
Procedure – Separately injected equal volumes( about 20 µL) of each of the standard solution and 
the test solution into the chromatograph, chromatographs was recorded and areas were measured 
for the major peaks. The quantity of each flavonoids in sample was calculated and given (Table 
4). 
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Estimation of phenol19: 
Method:HPLC 
Buffer: phosphate buffer 
Mobile phase: phosphate buffer with Acetonitrile 
Detection: UV(260nm) 
Column: C18 
Injection volume:20µl 
Standard solutions: gallic acid, ascorbic acid, ellagic acid, coumaric acid and tannic acid. 
From the peak responses of the relevant component obtained(Fig 14&15) the quantity of phenols 
in sample was calculated and given(Table 5). 
 
RESULTS AND DISCUSSION: 
Macroscopic features 
 TABLE-1                                                                   
 
 
                
 
 
 
 
 
 
 
MICROSCOPICAL FEATURES 
Transverse section (TS) of the wood: 
Wood is porous (having the pores or vessels) The growth – rings are fairly distinct. The vessels 
are circular or ovate . They are mostly solitary or less frequently radial multiples of two to four 
vessels. The vessels have very thick walls which are lignified. Most of the vessels  are open and 
some have gum deposits(Fig.2). The vessels are 100-200 µm wide.   
 s.no 
 
Parameters Observation 
1 Colour Orange- red 
2 Taste Bitter 
3 Odour Slight 
4 Surface Grained 
5 Texture Fine and even 
6 Shape Straight 
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Axial parenchyma :- 
 Parenchyma cells wich are vertically oriented are called axial parenchyma cells. The axial 
parenchyma is abundant . They occur as thin tangential layer along boundary of  the growth 
ring.Such parenchyma cells are called paratracheal parenchyma . The parenchyma cells are thick 
walled, lignified and have wide lumen(Fig.3).  
The xylem rays are seen in several closely running radial lines of parenchyma cells. The ray 
parenchyma cells are radially elongated, narrow lumened  and thick walled. They run in straight 
lines. Xylem fibres form the ground tissue of the wood. The fibres are angular in sectional view. 
They are compact; they have very thick, lignified walls. The cell lumen is reduced to a narrow hole 
(Fig.4). 
                                                                                                                                                                                                        
 
Fig 2  TS of wood showing vessel distributions.  
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Fig 3 TS of wood showing solitary vessels, growth ring. 
 
Fig 4 TS of wood showing radial multiples of vessels. 
G- gum deposition on the crosswall of the vessels; PPa- paratracheal parenchyma; BPa-boundary 
parenchyma; RM- radial multiples of vessels; Ve- vessels ; XF- xylem fibres; 
XP- xylem parenchyma; XR- xylem ray; GR-growth ring; SVe-solitary vessel. 
 
Tangential longitudinal section( TLS view ) 
In TLS view, the xylem rays spindle shaped; the vessels, axial parenchyma and xylem fibres are 
seen in vertical alignment (Fig.5). The rays are random in vertical orientation. So the rays are 
uniseriate , biseriate  or multiseriate . Thus the rays exhibit variations in seriation.The rays are 
either homocellular or heterocellular. The homocellular rays have uniform type of cells. The 
Mekala et. Al.,                                                                            Volume 4 – Issue 1  
 
Vol: 4(1) December  2015 
    40 
                                         www.ijopils.com 
  
heterocellular rays have two type cells: the cells in the middle part of the rays isodiametric; the 
cell at the ray are vertically elongated. The isodiametric cells in the middle part of the rays are 
called procumbet cells(Fig.6,7); those at the ends of the rays are 300-600 µm in height and 50-100 
µm thick. The ray cells are narrow and thick walled. 
 
 
 Fig 5 TLS of wood showing axial parenchyma  
 
Fig 6 TLS of wood showing gum, biseriate xylem rays. 
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Fig 7  TLS of wood showing horizontal , ribbon shaped ray. 
 
GPI- gum plate; Ve- vessel; XFi- xylem fibres; XPa- xylem parenchyma; XR- xylem rays 
APa- axial parenchyma; BR- biseriate ray; Gu-gum; MR- multiseriate ray; Pc- procumbent cells; 
UC- upright cells; Ve-vessel; XFi- xylem fibres;  XPa- xylem parenchyma ; XR- xylem ray. 
 
Radial  longitudinal sections of the wood( RLS view)  
In RLS view, the xylem rays appear as wide, and flat horizontal ribbon like bands. The xylem 
fibres, parenchyma  and the  vessels are at vertical rows at right angles to the rays. The procumbent 
cells of the ray are horizontally elongated, narrow and thick walled. The ray cells have dense 
simple pits (Fig .8 ). The upright cells are short, and squarish in shape.The axial parenchyma cells 
are long in vertical plane; they occur clusters of 2-4 rows (Fig .9) . The cells have minute circular 
pits. 
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 Fig 8 RLS of wood  showing horizontal ribbon shaped rays 
 
 
Fig 9  RLS of wood showing ray cells enlarged. 
Pc- procumbent cells; Ve- vessel; XFi- xylem fibres;  XPa- xylem parenchyma; XR- xylem ray ; 
Uc – upright cells 
 
Powder microscopic  observations 
 
The powder preparations of the wood shows the following elements when observed under the 
microscope 
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(i) Fibres:-Long, thin needle shaped fibres are abundant in the powder. They have thick lignified 
walls and much reduced lumen. The fibres are 600- 800 µm long and 20µm thick(Fig.10). 
 
 
 
 
 Fig 10  xylem fibres 
Pa- parenchyma;  XFi-xylem fibres. 
(ii) vessel elements:-Vessel elements are fairly common in the powder . vessel elements of the 
powder shows long thick vessel elements with prominent bordered pits, short wide vessel element 
and wide, short barrel shaped vessel element were identified.. These vessels elements are 250 µm 
long and 140µm wide .These are aiso wide, very short and drum shaped vessel elements which are 
130µm long and 250 µm wide. The vessel elements have dense multiseriate elliptical bordered 
pits(Fig.11).  
(iii)parenchyma cells :-Rectangular , short parenchyma cells are occasionally  seen. The cells are 
thick walled with dense simple pits. The cells are 90 µm long and 15 µm wide ( Fig.11). 
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Fig. 11  pitted vessel 
Pa – parenchyma cells; Pe- perforation; Pi- pits; Ve- vessel element. 
TABLE-2 Preliminary phytochemical analysis of powder and extract of heartwood of 
caesalpinia sappan 
S. NO PHYTOCHEMICAL TESTS POWDER HYDROALCOHOLIC EXTRACT 
1 Alkaloids           -                 - 
2 Carbohydrates            +                 + 
3 Flavonoids            +                 + 
4 Glycosides           +                 + 
5 Fixed oil and fats            +                 - 
6 Phytosterols            +                + 
7 Phenolic compounds            +                + 
8 Proteins,and aminoacids           +                 - 
9 Resins            +                 - 
10 Saponins            +                 + 
11 Terpenoids            +                 + 
12 Tannins            +                 + 
13 Gums and mucilage            +                  - 
 
    +ve indicates presence, and  -ve indicates absence. 
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Table 3: Quantitative estimation of Heavy Metals in heartwood powder of  Caesalpinia 
sappan  
S.NO  HEAVY METALS OBSERVATION(PPM) STANDARD LIMITS 
1 Mercury  Not detected Not more than 5ppm 
2 Arsenic Not detected Not more than 5ppm 
3 Lead 0.002 Not more than 10ppm 
4 Cadmium Not detected Not more than 0.03ppm 
 
QUANTITATIVE ESTIMATION 
A) ESTIMATION  OF FLAVONOIDS 
  
Fig 12  standard curves for Flovonoids 
 
 
 
Fig 13 Hydroalcoholic extract sample curves for flavonoids. 
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TABLE-4(Flavonoids quantity) 
FLAVONOIDS  SAPPANWOOD POWDER 
                  PER GM 
SAPPAN WOOD ETRACT 
              PER ML 
Rutin                      0.78mg             0.934mg 
Quercetin                      0.146mg             0.184mg 
Gallangin                     0.074mg              0.158mg 
 
B) ESTIMATION OF PHENOLS 
 
Fig 14 Standard curves for phenol 
 
 
Fig 15 Sample curves for hydoalcoholic extract for phenol 
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TABLE-5(phenols quantity) 
 PHENOLS SAPPAN POWDER 
     PER ML 
 SAPPAN EXTRACT 
             PER ML 
Gallic acid      0.468mg 0.519mg 
Tannic acid      0.029mg 0.083mg 
 
Ellagic acid, coumaric acid, and ascorbic acid were also identified in smaller amount. 
 
CONCLUSION:  
A medicinally useful plants in the Indian system of medicine Caesalpinia sappan Linn., belonging 
to the family Caesalpiniaceae was selected. The pharmacognostical studies carried out provides a 
set of diagnostic macroscopic, microscopic features and physio chemical parameters that can be 
used in confirming the identity of these plants and to detect adulterants and their nature. Sappan 
wood with high therapeutic effect and vast folklore uses is worth studying more that might provide 
a rich natural resource of lead compounds for drug development. Medicinally the wood is 
recommended as a substitute for logwood. It has vast uses in ayurveda  and yunani.   
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HERBAL FORMULATION DEVELOPMENT ON HEARTWOOD OF 
Caesalpinia sappan FOR HYPOLIPIDEMIC AND ANTI-OBESITY 
ACTIVITY 
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Abstract  
 
Cardiovascular disease (CVD), particularly coronary heart disease (CHD) and cerebro 
vascular accident (CVA) is the leading cause of medically certified death in both developed 
as well as developing countries. Hyperlipidemia and obesity is one of the greatest risk factors 
in the manifestation and development of CHD and CVA. Medicinal plants have been shown 
to play a major role in treating hyperlipidemia and obesity and considering this, the present 
study was designed to develop an herbal capsules formulation on heartwood of Caesalpinia 
sappan for hypolipidemic and anti-obesity activity. The hydro alcoholic extract (1:1) on 
heartwood of Caesalpinia sappan was prepared by cold maceration method and then it was 
formulated into a hard gelatin herbal capsule. The quantitative estimation of 
phytoconstituents especially of flavonoids and phenolic content in extract and formulated 
herbal capsule was estimated by HPLC method showed the presence of Rutin, Quercetin, 
Gallic acid, Ascorbic acid and tannic acid. Hydro alcoholic extract of Caesalpinia sappan 
(HECS) herbal capsule was evaluated for acute toxicity studies in albino wistar rats and 
showed no toxicity up to 2000mg/kg. In-vivo evaluation of high fat diet (HFD) induced 
obesity in rats were carried out for HECS herbal capsule .The studies showed HECS herbal 
capsule(250mg/kg and 500mg/kg) significantly reduced the elevated levels of body weight, 
total cholesterol, triglycerides, LDL-cholesterol, VLDL-cholesterol, SGPT and SGOT  and 
elevated the decreased level of HDL-cholesterol. These results suggest that, HECS capsule 
possess good hypolipidemic and anti-obesity activity, which may be due to its flavonoid, 
saponin and phenolic content.             
 
 
